Certain disorders involving the immune mechanism

D3_IMMUNEMECHANISM

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

8312

6. Filter based on genotype QC (FinnGen only)

8312

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2

Similar endpoints

List of similar endpoints to Certain disorders involving the immune mechanism based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 50702 26913 23461
Only index persons 44339 23677 20662
Unadjusted period prevalence (%)
Whole population 0.71 0.77 0.66
Only index persons 0.83 0.87 0.79
Median age at first event (years)
Whole population 46.66 49.29 43.59
Only index persons 45.47 47.89 42.69

-FinnGen-

Key figures

All Female Male
Number of individuals 8312 4595 3717
Unadjusted period prevalence (%) 1.60 1.57 1.64
Median age at first event (years) 47.28 47.61 46.87

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
7481
Matched controls
74811
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UGC12
NOMESCO Finland
Flexible bronchoscopy
6.4
323.0
1313
2413
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
12011.0
323.0
1047
*
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
+∞
323.0
1270
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
6.2
323.0
1642
3223
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
323.0
4498
21887
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
+∞
323.0
833
*
H02AB06
ATC
prednisolone; systemic
3.6
323.0
4736
24360
D86.3
ICD-10 Finland
Sarcoidosis of skin
1829.8
323.0
335
*
13599
ICD-8 Finland
Sarcoidosis, Unspecified
+∞
323.0
457
*
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
1738.1
323.0
763
5
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
13030.5
323.0
1122
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
323.0
329
*
I41.8*D86.8
ICD-10 Finland
Sarcoid myocarditis
3188.3
323.0
316
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
9.4
323.0
1148
1408
D86.0
ICD-10 Finland
Sarcoidosis of lung
+∞
323.0
1870
*
1350A
ICD-9 Finland
Sarcoidosis[SARCOIDOSIS]
+∞
323.0
426
*
13597
ICD-8 Finland
Sarcoidosis, Suspecta
+∞
323.0
524
*
132
Kela drug reimbursment
Sarcoidosis
+∞
323.0
897
*
TGC00
NOMESCO Finland
Bronchial lavation
12.6
323.0
714
623
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
270.4
258
*
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
889.1
264.1
258
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
263.0
251
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
244.1
233
*
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
187.0
242.8
253
14
GEA00
NOMESCO Finland
Mediastinoscopy
58.3
236.9
281
50
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
234.6
224
*
XG410
NOMESCO Finland
Flow-volume spirometry
6.0
233.9
695
1260
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
7.5
231.7
580
831
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.5
230.8
579
832
D86
ICD-10 Finland
Sarcoidosis
567.2
223.6
221
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
14.4
221.3
386
281
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
221.1
2726
14737
L04AA06
ATC
mycophenolic acid; systemic
10.7
210.1
423
418
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.2
200.2
825
2123
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.0
199.0
1372
5290
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
196.7
188
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.2
186.7
770
1977
C03CA01
ATC
furosemide; systemic
2.3
186.2
2193
11379
I41.8
ICD-10 Finland
Myocarditis in other diseases classified elsewhere
616.3
183.5
181
*
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
20.0
182.4
280
145
L04AX01
ATC
azathioprine; systemic
4.8
175.4
626
1388
127
Kela drug reimbursment
Transplant complication
10.3
174.8
357
361
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.8
172.7
419
568
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.4
172.1
918
2926
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
8.0
169.8
404
531
R50.9
ICD-10 Finland
Fever, unspecified
2.7
168.9
1369
5777
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
6.4
167.2
463
758
ZX120
NOMESCO Finland
Intravenous
3.1
159.9
990
3508
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
13.3
159.6
287
223
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.6
159.2
589
1352
Z94.0
ICD-10 Finland
Kidney transplant status
12.0
153.7
290
250
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
4.1
150.1
631
1637
M05BA04
ATC
alendronic acid; oral
3.4
149.7
800
2539
D81.4
ICD-10 Finland
Nezelof syndrome
+∞
149.4
143
*
H02AB04
ATC
methylprednisolone; systemic
2.5
148.5
1362
6116
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
148.0
1789
9222
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.9
147.2
650
1762
A02BC02
ATC
pantoprazole; systemic
1.9
146.6
4894
37309
A11CC03
ATC
alfacalcidol; systemic
6.6
138.8
375
592
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.9
138.6
931
3463
D80.2
ICD-10 Finland
Selective deficiency of immunoglobulin A [IgA]
1361.5
136.9
133
*
R03AC02
ATC
salbutamol; inhalant
1.8
136.5
4022
29002
J45.9
ICD-10 Finland
Asthma, unspecified
2.3
135.0
1534
7634
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
131.9
1779
9554
A12AA04
ATC
calcium carbonate; oral
8.3
130.9
303
380
J01MA12
ATC
levofloxacin; systemic
2.2
130.6
1545
7821
TK800
NOMESCO Finland
Hemodialysis
6.4
128.2
353
571
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
128.0
2277
13650
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
44.2
125.4
156
36
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
12.7
124.3
228
185
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
20.4
121.6
185
93
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
120.5
1767
9769
R06.0
ICD-10 Finland
Dyspnoea
2.0
119.9
1909
10910
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
119.1
114
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
118.6
1697
9280
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
117.0
112
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
8.8
114.9
256
301
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
8.3
114.4
264
329
WW200
NOMESCO Finland
Immunization
4.9
113.2
391
829
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.2
112.4
1363
6920
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
10.7
112.2
224
216
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.3
111.0
443
1087
6BA02
NOMESCO Finland
NA
31.0
110.8
149
49
N18.8
ICD-10 Finland
Other chronic renal failure
5.4
110.8
354
688
GD1AD
NOMESCO Finland
Thorax CT examination
3.8
109.6
493
1349
M14.8*D86.8
ICD-10 Finland
Arthropathy in sarcoidosis
+∞
108.6
104
*
M04AA01
ATC
allopurinol; systemic
2.4
108.2
1021
4582
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
108.0
2135
13128
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
14.1
107.0
187
136
H02AB07
ATC
prednisone; oral
2.2
106.4
1209
5942
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.2
106.1
601
1972
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
16.7
106.1
173
106
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.2
105.8
614
2050
D84.18
ICD-10 Finland
Other specified defect in the complement system
+∞
105.4
101
*
D81.0
ICD-10 Finland
Severe combined immunodeficiency [SCID] with reticular dysgenesis
+∞
102.3
98
*
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
15.0
101.7
173
118
137
Kela drug reimbursment
Uraemia requiring dialysis
10.6
100.7
201
194
N18.0
ICD-10 Finland
End-stage renal disease
9.5
100.7
213
229
B03XA02
ATC
darbepoetin alfa; parenteral
6.3
99.5
276
450
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
99.5
1196
6013
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.6
99.3
796
3261
L04AD01
ATC
ciclosporin; systemic
6.0
99.1
285
487
R03BA02
ATC
budesonide; inhalant
2.0
98.4
1410
7636
J45.1
ICD-10 Finland
Nonallergic asthma
2.8
97.5
677
2544
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
8.3
97.0
222
273
J01MA14
ATC
moxifloxacin; systemic
2.6
96.9
797
3312
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
10.3
95.9
194
192
N16.2*D86.8
ICD-10 Finland
Renal tubulo-interstitial disorders in sarcoidosis
+∞
93.9
90
*
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
3.1
93.8
555
1874
FPG32
NOMESCO Finland
Implantation of cardioverter-defibrillator with atrial and ventricular electrodes
12.6
92.7
170
138
KA1AE
NOMESCO Finland
Kidney ultrasound examination
5.0
92.0
314
656
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
+∞
91.8
88
*
D84.9
ICD-10 Finland
Immunodeficiency, unspecified
+∞
91.8
88
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
90.6
850
3782
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
9.9
89.0
184
190
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
88.0
1313
7191
FM1JR
NOMESCO Finland
Heart, extensive metabolic PET with CT
40.3
87.8
111
28
H04.10
ICD-10 Finland
Dry eye syndrome
2.4
87.7
821
3644
C07AB07
ATC
bisoprolol; oral
1.6
86.7
3203
23441
R05
ICD-10 Finland
Cough
1.9
85.7
1475
8512
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.6
85.5
679
2756
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.6
84.9
408
1176
Z49.0
ICD-10 Finland
Preparatory care for dialysis
9.1
84.6
183
205
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
21.3
84.5
126
60
H02AB09
ATC
hydrocortisone; systemic
4.7
83.3
299
659
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
21.9
83.2
123
57
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.9
82.8
1459
8477
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
82.4
79
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
82.2
2644
18546
Z3231
NOMESCO Finland
Registered nurse
1.7
81.5
2044
13330
H22.1*D86.8
ICD-10 Finland
Iridocyclitis in sarcoidosis
+∞
81.4
78
*
B05DA
ATC
Isotonic solutions
10.3
80.0
162
161
TAB00
NOMESCO Finland
Lumbar puncture
3.2
79.9
443
1424
R80
ICD-10 Finland
Isolated proteinuria
10.0
79.2
163
167
Z49.2
ICD-10 Finland
Other dialysis
10.4
78.6
158
155
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.4
77.5
729
3234
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.0
77.4
222
378
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.5
74.8
629
2629
WX892
NOMESCO Finland
Monitored bed care
2.5
74.6
642
2717
ZXE00
NOMESCO Finland
One hour or less
1.6
74.6
2844
20716
J01FF01
ATC
clindamycin; systemic
1.7
74.6
1985
13112
UJF32
NOMESCO Finland
Coloscopy
1.7
74.1
1835
11857
ZXD05
NOMESCO Finland
Urgent procedure
1.6
72.5
2226
15284
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.3
71.7
387
1219
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.8
71.5
492
1828
L04AA01
ATC
[U] ciclosporin; systemic
5.7
71.0
211
376
I44.2
ICD-10 Finland
Atrioventricular block, complete
4.6
70.9
256
567
H20.1
ICD-10 Finland
Chronic iridocyclitis
7.4
70.9
174
239
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.2
69.5
761
3625
XW000
NOMESCO Finland
Bone marrow biopsy
3.2
69.5
388
1253
J01FA06
ATC
roxithromycin; oral
1.6
69.1
2873
21257
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
69.1
1278
7497
J47
ICD-10 Finland
Bronchiectasis
5.5
69.0
214
401
Z2221
NOMESCO Finland
Medical doctor
1.6
67.7
2015
13661
B05DB
ATC
Hypertonic solutions
10.3
67.6
136
134
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.7
67.0
480
1827
205
Kela drug reimbursment
Chronic hypertension
1.7
66.2
1824
12094
J01DB01
ATC
cefalexin; oral
1.6
66.1
5884
51864
N03.3
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
45.4
65.8
81
18
JN4BD
NOMESCO Finland
Extensive body CT
2.1
65.7
830
4205
D84.1
ICD-10 Finland
Defects in the complement system
+∞
65.7
63
*
C08CA01
ATC
amlodipine; oral
1.6
65.5
2343
16641
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.5
65.4
557
2338
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
3.0
64.2
398
1380
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.2
64.2
731
3537
N02AX02
ATC
tramadol; systemic, rectal
1.5
63.7
2944
22203
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.3
63.6
613
2741
V03AE01
ATC
polystyrene sulfonate; oral
6.6
63.2
168
259
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.7
63.2
476
1864
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
63.2
2719
20157
Z3226
NOMESCO Finland
Physiotherapist
1.8
62.9
1362
8387
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
62.7
1511
9612
N02BE01
ATC
paracetamol; systemic, rectal
1.6
62.6
6114
54658
R03BA08
ATC
ciclesonide; inhalant
2.2
62.3
662
3104
A02BC01
ATC
omeprazole; systemic
1.6
62.2
1916
13051
TGD00
NOMESCO Finland
Needle biopsy of lung
12.4
62.2
114
93
D84.19
ICD-10 Finland
Unspecified defect in the complement system
+∞
61.5
59
*
D89.9
ICD-10 Finland
Disorder involving the immune mechanism, unspecified
+∞
61.5
59
*
V03AE02
ATC
sevelamer; oral
10.8
61.1
120
113
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.1
60.4
360
1215
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
59.3
1152
6834
R4110
NOMESCO Finland
Physiotherapy
1.6
59.1
1864
12745
L52
ICD-10 Finland
Erythema nodosum
9.6
58.9
123
130
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
57.3
3573
28548
P01BA02
ATC
hydroxychloroquine; oral
2.2
57.2
632
3009
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
56.5
983
5610
WZC30
NOMESCO Finland
Teaching
1.9
56.3
969
5510
TFJ02
NOMESCO Finland
Muscle biopsy of heart
24.5
56.3
80
33
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
3.1
55.8
322
1063
J01MA02
ATC
ciprofloxacin; systemic
1.5
55.5
2610
19583
G53.2*D86.8
ICD-10 Finland
Multiple cranial nerve palsies in sarcoidosis
+∞
55.3
53
*
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
10.4
55.1
110
107
G47.3
ICD-10 Finland
Sleep apnoea
1.7
54.8
1510
9926
J01AA02
ATC
doxycycline; systemic
1.5
54.7
5480
48142
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
54.6
2391
17635
196
Kela drug reimbursment
Paricalcitol and cinacalcet
11.6
54.5
103
90
B03XA01
ATC
erythropoietin; parenteral
7.6
54.3
130
173
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.8
54.1
369
1361
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
12.9
54.0
97
76
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
53.8
2930
22644
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
53.4
1154
7065
R03DC03
ATC
montelukast; oral
1.8
53.1
1142
6978
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
52.9
1477
9734
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
52.3
2767
21213
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
51.9
798
4347
ZX108
NOMESCO Finland
Inhalation
7.7
51.2
122
161
N19
ICD-10 Finland
Unspecified kidney failure
3.3
51.0
274
860
R03BA01
ATC
beclometasone; inhalant
1.8
50.5
1006
5990
R03AK08
ATC
formoterol and beclometasone; inhalant
2.9
50.4
320
1127
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
4.5
50.4
185
418
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.2
50.0
273
867
Z2446
NOMESCO Finland
Social worker
2.2
49.1
523
2446
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
48.9
2261
16780
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
48.8
2612
19994
J05AB11
ATC
valaciclovir; oral
1.8
48.3
904
5270
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
6.6
48.2
128
198
A46
ICD-10 Finland
Erysipelas
1.8
48.0
935
5519
N08.2*D89.82
ICD-10 Finland
Nepropathy caused by deposition of the light chain of the immunoglobulins
+∞
48.0
46
*
D81.8
ICD-10 Finland
Other combined immunodeficiencies
+∞
48.0
46
*
J01CA04
ATC
amoxicillin; systemic
1.5
47.6
5644
50381
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.9
47.5
298
1041
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.9
46.7
794
4475
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
46.6
761
4231
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
46.2
969
5856
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
46.1
751
4169
UJF30
NOMESCO Finland
Ileoscopy through colon
2.0
45.8
678
3633
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
8.7
45.6
100
116
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.1
45.4
544
2678
A41.9
ICD-10 Finland
Sepsis, unspecified
3.0
45.2
277
951
C09AA02
ATC
enalapril; systemic
1.6
45.1
1265
8298
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.2
45.1
501
2386
XG474
NOMESCO Finland
Exhalation nntrogen oxide
3.1
45.0
260
860
SPAT1262
SPAT
Handing over of treatment supplies
1.6
44.6
1217
7927
E0000UV
ATC
NA
1.4
44.2
2601
20174
R01AD09
ATC
mometasone; nasal
1.4
44.1
3034
24250
R03AK07
ATC
formoterol and budesonide; inhalant
1.6
43.9
1315
8769
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.0
43.7
569
2898
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
43.7
1157
7472
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
43.6
3663
30344
TK820
NOMESCO Finland
Peritoneal dialysis
9.4
43.3
91
98
WX002
NOMESCO Finland
Sedation and analgesia
1.6
43.1
1304
8714
J01DA01
ATC
[U] cefalexin; systemic
1.4
43.0
4282
36530
5828A
ICD-9 Finland
Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]
47.6
42.9
52
11
D80.6
ICD-10 Finland
Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
+∞
42.7
41
*
D83.1
ICD-10 Finland
Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
+∞
42.7
41
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
4.7
42.7
151
329
R03BA05
ATC
fluticasone; inhalant
1.6
42.7
1234
8149
ZXA10
NOMESCO Finland
Bilateral
1.6
42.6
1223
8062
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
42.5
527
2631
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
9.8
42.4
87
90
XF404
NOMESCO Finland
Ambulatory ECG
1.9
42.3
631
3391
M25.5
ICD-10 Finland
Pain in joint
1.5
41.8
1878
13749
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
19.8
41.7
63
32
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.1
41.6
529
2667
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.1
41.4
522
2623
XQ800
NOMESCO Finland
Prick test
2.0
41.0
548
2817
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
5.2
41.0
130
252
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.5
40.9
351
1473
ZXA00
NOMESCO Finland
Right side
1.5
40.7
1746
12651
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
40.6
774
4525
A07AA02
ATC
nystatin; oral
2.2
40.3
441
2085
WW500
NOMESCO Finland
Blood transfusion
2.6
40.1
300
1167
N08.2*D69.0
ICD-10 Finland
Glomerular disorders in Henoch(-Schönlein) purpura
38.7
39.6
50
13
N16.2
ICD-10 Finland
Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism
+∞
39.6
38
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
39.6
1395
9656
M13.9
ICD-10 Finland
Arthritis, unspecified
2.0
39.3
504
2551
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.9
39.3
613
3345
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
8.2
39.2
89
110
J01FA09
ATC
clarithromycin; systemic
1.4
39.1
2109
15992
1440
FHL
Mediastinoscopy
73.9
38.9
44
6
A02BC03
ATC
lansoprazole; oral
1.5
38.3
1904
14188
N03AX16
ATC
pregabalin; oral
1.5
38.0
1527
10874
J45.8
ICD-10 Finland
Mixed asthma
2.9
38.0
247
883
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.6
37.9
286
1117
1240
FHL
Bronchoscopy
5.8
37.8
109
189
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.0
37.7
523
2729
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
2.7
37.6
267
1009
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.0
37.6
228
779
D84.8
ICD-10 Finland
Other specified immunodeficiencies
+∞
37.5
36
*
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
9.5
37.5
78
83
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
37.4
1135
7563
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
37.3
1062
6964
J02AC01
ATC
fluconazole; systemic
1.4
37.2
2572
20374
R01AD08
ATC
fluticasone; nasal
1.5
37.0
1870
13962
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.0
37.0
473
2388
AP4
HP
Myocardial biopsy
19.4
36.9
56
29
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
6.2
36.7
101
165
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
5.6
36.7
109
196
B01AA03
ATC
warfarin; systemic
1.6
36.6
1134
7594
H05BX01
ATC
cinacalcet; oral
7.7
36.5
86
113
H26.3
ICD-10 Finland
Drug-induced cataract
7.4
36.4
88
120
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.8
36.3
237
850
H30.2
ICD-10 Finland
Posterior cyclitis
12.3
36.3
66
54
JN4AD
NOMESCO Finland
Body CT examination
2.0
36.0
506
2654
R03AC03
ATC
terbutaline; inhalant
1.7
35.9
916
5829
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
35.6
579
3202
FM1CG
NOMESCO Finland
Extensive examination of hear with high intensity magnet
9.2
35.6
75
82
M10.9
ICD-10 Finland
Gout, unspecified
2.1
35.3
414
2013
B01AB05
ATC
enoxaparin; parenteral
1.4
35.3
1922
14537
J01FA10
ATC
azithromycin; systemic
1.4
35.1
3902
33358
A02BC05
ATC
esomeprazole; systemic
1.4
35.0
2667
21423
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
34.9
1684
12435
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
6.7
34.9
90
135
P01AB01
ATC
metronidazole; oral, rectal
1.4
34.9
2551
20346
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
34.8
602
3400
RD210
NOMESCO Finland
NA
3.4
34.8
176
529
R31
ICD-10 Finland
Unspecified haematuria
1.8
34.7
603
3410
V03AE03
ATC
lanthanum carbonate; oral
10.5
34.7
68
65
C03DA01
ATC
spironolactone; oral
1.8
34.6
659
3844
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
9.2
34.6
73
80
3AC01
NOMESCO Finland
NA
4.8
34.4
117
246
D84.0
ICD-10 Finland
Lymphocyte function antigen-1 [LFA-1] defect
+∞
34.4
33
*
D83.8
ICD-10 Finland
Other common variable immunodeficiencies
+∞
34.4
33
*
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
34.3
1629
11983
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
13.8
34.2
59
43
C02AC05
ATC
moxonidine; oral
2.3
34.1
318
1393
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.3
33.9
317
1391
R03BB04
ATC
tiotropium bromide; inhalant
1.8
33.8
604
3446
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
33.8
2066
15940
C01CA24
ATC
epinephrine; parenteral
2.1
33.8
426
2139
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.8
33.8
223
807
GD1LA
NOMESCO Finland
GD
4.2
33.6
131
316
R51.80
ICD-10 Finland
Headache
1.6
33.5
939
6119
J05AB01
ATC
aciclovir; systemic
1.5
33.5
1338
9485
I47.2
ICD-10 Finland
Ventricular tachycardia
3.3
33.4
171
519
JN3AD
NOMESCO Finland
Abdominal CT examination
1.9
33.4
511
2763
D84.11
ICD-10 Finland
Hereditary angioedema type I
+∞
33.3
32
*
N082, D898
ICD-10 Finland
NA
+∞
33.3
32
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
33.3
357
1670
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
33.1
708
4278
WX110
NOMESCO Finland
Local anesthesy
1.3
33.1
4669
41256
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
33.0
3024
24966
M14.8
ICD-10 Finland
Arthropathies in other specified diseases classified elsewhere
63.6
33.0
38
6
ZX112
NOMESCO Finland
Subcutaneous
3.2
33.0
179
568
SPAT1255
SPAT
Intravenous administration of medicine
2.0
32.9
443
2283
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
32.9
1509
11007
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
3.8
32.8
141
372
ZXA05
NOMESCO Finland
Left side
1.5
32.6
1583
11673
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.2
32.4
334
1536
D81.9
ICD-10 Finland
Combined immunodeficiency, unspecified
+∞
32.3
31
*
D07AC01
ATC
betamethasone; topical
1.4
32.1
2186
17160
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.9
32.0
474
2534
321
Kela drug reimbursment
Paricalcitol and cinacalcet
7.8
31.7
74
96
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.4
31.6
157
466
C09CA01
ATC
losartan; oral
1.5
31.5
1479
10827
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
5.0
31.4
103
209
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
31.7
31.2
41
13
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
31.1
659
3967
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
31.0
864
5614
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
30.9
777
4910
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
30.8
1812
13839
R60.0
ICD-10 Finland
Localized oedema
1.7
30.7
656
3957
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
30.6
412
2120
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.9
30.6
191
668
R03DA04
ATC
theophylline; systemic, rectal
2.3
30.6
305
1380
PJA10
NOMESCO Finland
Exploration of lymph nodes
4.3
30.5
116
274
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
30.4
1289
9232
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
2.7
30.3
212
795
N08.2*D57.8
ICD-10 Finland
Glomerular disorders in sickle-cell disorders
+∞
30.2
29
*
J46
ICD-10 Finland
Status asthmaticus
2.8
30.1
201
733
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
30.0
1664
12564
I44.1
ICD-10 Finland
Atrioventricular block, second degree
3.3
29.9
153
465
C08CA02
ATC
felodipine; oral
1.8
29.7
547
3152
WX402
NOMESCO Finland
General anaesthesia
1.5
29.6
1075
7439
D69.0
ICD-10 Finland
Allergic purpura
6.2
29.4
80
130
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.7
29.3
619
3718
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
8.8
29.3
63
72
D89.0
ICD-10 Finland
Polyclonal hypergammaglobulinaemia
+∞
29.2
28
*
338
Kela drug reimbursment
C1-esterase inhibitor, icatibant and conestat alfa
+∞
29.2
28
*
M36.8*D80.1
ICD-10 Finland
Systemic disorders of connective tissue in hypogammaglobulinaemia
+∞
29.2
28
*
J32.4
ICD-10 Finland
Chronic pansinusitis
3.6
29.1
134
375
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
29.1
534
3074
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.6
28.9
135
383
S97
ICPC
Chronic ulcer skin
2.1
28.8
339
1654
SPAT1263
SPAT
Sampling
1.3
28.5
2680
22058
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
6.7
28.4
73
110
C07AG02
ATC
carvedilol; oral
2.0
28.2
368
1870
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
28.2
817
5355
E83.50
ICD-10 Finland
Hypercalcemia
3.9
28.2
117
300
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
28.1
2381
19275
N03.8
ICD-10 Finland
Chronic nephritic syndrome, other
15.4
28.1
46
30
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.1
28.0
325
1576
R03AC12
ATC
salmeterol; inhalant
2.2
27.9
290
1338
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
5.4
27.9
85
159
N02AA05
ATC
oxycodone; systemic
1.6
27.8
838
5546
M81.4
ICD-10 Finland
Drug-induced osteoporosis
9.3
27.8
58
63
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
27.7
1239
8955
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
4.0
27.6
114
291
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
27.6
1185
8492
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
4.5
27.5
100
227
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.7
27.4
665
4155
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
27.3
778
5076
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.9
27.2
171
601
UKC02
NOMESCO Finland
Cystoscopy
1.5
27.2
904
6120
A02BA02
ATC
ranitidine; systemic
1.5
27.2
1197
8619
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
6.3
27.1
73
117
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
27.1
698
4433
D89.1
ICD-10 Finland
Cryoglobulinaemia
+∞
27.1
26
*
D84.13
ICD-10 Finland
Hereditary angioedema type III
+∞
27.1
26
*
A01AB09
ATC
miconazole; local oral
1.7
27.0
547
3241
R4190
NOMESCO Finland
Nutritional therapy
2.3
27.0
257
1136
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.4
27.0
234
987
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.7
27.0
560
3344
E66.01
ICD-10 Finland
Obesity due to excess calories
1.8
26.8
510
2967
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
26.7
1524
11526
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.5
26.7
216
879
R01AD12
ATC
fluticasone furoate; nasal
1.4
26.6
1854
14517
C09CA06
ATC
candesartan; oral
1.4
26.6
1318
9709
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.2
26.5
142
448
51925
ICD-8 Finland
Other diseases of respiratory system, Infiltratio pulmonis NUD
11.2
26.5
50
45
XCK10
NOMESCO Finland
Photography of fundus of eye
1.7
26.4
624
3870
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.7
26.3
554
3326
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
5.5
26.3
79
146
R53
ICD-10 Finland
Malaise and fatigue
1.5
26.2
1195
8660
M05BA07
ATC
risedronic acid; oral
2.5
26.2
204
815
R06.2
ICD-10 Finland
Wheezing
2.1
26.1
294
1405
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
26.1
739
4811
ZY010
NOMESCO Finland
Hospital outpatient
2.1
26.1
320
1588
L03AA02
ATC
filgrastim; parenteral
2.6
26.1
196
767
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
9.7
26.1
53
55
D89.2
ICD-10 Finland
Hypergammaglobulinaemia, unspecified
+∞
26.0
25
*
UJF92
NOMESCO Finland
Capsular endoscopy
2.8
25.9
168
604
R03AC13
ATC
formoterol; inhalant
2.0
25.7
327
1647
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
25.7
507
2985
GE1BE
NOMESCO Finland
Mediastinal ultrasound examinaiton through oesophagus
14.4
25.6
43
30
58209
ICD-8 Finland
Chronic nephritis, Unspecified
20.1
25.6
38
19
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
12.9
25.6
45
35
R5140
NOMESCO Finland
Monitoring the use of the aid
1.6
25.5
658
4181
H03AA01
ATC
levothyroxine sodium; systemic
1.4
25.4
1394
10459
N03AX12
ATC
gabapentin; oral
1.5
25.4
940
6519
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
15.9
25.3
41
26
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
4.7
25.3
87
187
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
25.2
973
6808
R06AE07
ATC
cetirizine; oral
1.3
25.2
2786
23353
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
2.9
25.2
158
556
F1246
NOMESCO Finland
NA
19.1
25.1
38
20
D89.8
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
25.0
24
*
B06AC02
ATC
icatibant; parenteral
+∞
25.0
24
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.9
24.9
103
264
C07AB02
ATC
metoprolol; systemic
1.4
24.8
1169
8514
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
24.8
1136
8231
R03AK11
ATC
formoterol and fluticasone; inhalant
2.6
24.8
184
714
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
9.7
24.6
50
52
RS220
NOMESCO Finland
NA
3.5
24.5
116
334
S18
ICPC
Laceration/cut
1.3
24.4
2595
21598
PH1AC
NOMESCO Finland
Flebography of over extremity with X-ray
3.8
24.4
104
274
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.9
24.2
352
1867
D07AC13
ATC
mometasone; topical
1.4
24.2
1797
14178
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.9
24.1
150
522
R03BB01
ATC
ipratropium bromide; inhalant
2.3
24.1
224
982
C08CA13
ATC
lercanidipine; oral
1.6
24.0
750
4995
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.8
24.0
406
2271
K77.8*D86.8
ICD-10 Finland
Hepatic granulomas in sarcoidosis
+∞
24.0
23
*
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
6.9
23.9
60
88
AA1AD
NOMESCO Finland
CT of head and brain
1.4
23.9
1385
10481
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
6.3
23.8
64
103
M79.6
ICD-10 Finland
Pain in limb
1.3
23.8
2177
17720
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
12.8
23.8
42
33
ZX121
NOMESCO Finland
Central venous catheter
6.1
23.8
65
107
N08.2*D59.3
ICD-10 Finland
Glomerular disorders in haemolytic-uraemic syndrome
240.7
23.6
24
*
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.8
23.6
407
2293
D07AD01
ATC
clobetasol; topical
1.5
23.6
939
6605
GD1DG
NOMESCO Finland
Extremely extensive MRI examination of pleura with high field magnet
41.5
23.6
29
7
WX722
NOMESCO Finland
PEEP
2.0
23.5
307
1564
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
3.1
23.5
130
421
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.6
23.5
654
4236
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
23.4
1441
11013
C09AA05
ATC
ramipril; oral
1.4
23.3
1385
10517
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.1
23.3
258
1228
E66.8
ICD-10 Finland
Other obesity
1.9
23.3
340
1806
K65.0
ICD-10 Finland
Acute peritonitis
3.8
23.3
99
261
XG405
NOMESCO Finland
Education on PEF monitoring
3.2
23.2
122
381
TK810
NOMESCO Finland
Hemofiltration
5.1
23.2
74
147
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
23.2
524
3207
J31.0
ICD-10 Finland
Chronic rhinitis
1.7
23.2
492
2956
D70.82
ICD-10 Finland
Drug-induced neutropenia
3.2
23.1
125
398
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
23.1
1707
13437
207
Kela drug reimbursment
Chronic arrhythmias
1.5
23.1
757
5101
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
17.2
23.0
36
21
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.8
22.9
385
2150
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
22.8
682
4492
J20
ICD-10 Finland
Acute bronchitis
1.6
22.8
564
3538
L04AA05
ATC
[U] tacrolimus; systemic
17.6
22.6
35
20
B34.9
ICD-10 Finland
Viral infection, unspecified
2.5
22.6
184
755
T78.3
ICD-10 Finland
Angioneurotic oedema
3.4
22.5
112
336
B01AB04
ATC
dalteparin; parenteral
2.0
22.4
313
1638
J01DA06
ATC
[U] cefuroxime; systemic
1.5
22.4
910
6428
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.0
22.2
290
1478
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.7
22.2
503
3083
R42
ICD-10 Finland
Dizziness and giddiness
1.4
22.1
1219
9125
A04AA01
ATC
ondansetron; systemic, rectal
1.8
22.1
402
2305
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.4
22.0
110
331
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
7.1
22.0
54
77
R05
ICPC
Cough
1.4
22.0
1315
9986
2790B
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[DEFICIENTIA IMMUNOGLOBULINI A]
+∞
21.9
21
*
N08.2*D89.1
ICD-10 Finland
Glomerular disorders in cryoglobulinaemia
+∞
21.9
21
*
A10BH05
ATC
linagliptin; oral
2.0
21.9
274
1372
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
7.4
21.8
52
71
J01FA15
ATC
telithromycin; oral
1.6
21.7
647
4258
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.9
21.7
319
1701
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.7
21.6
149
554
I50.0
ICD-10 Finland
Congestive heart failure
1.8
21.6
353
1952
R04.0
ICD-10 Finland
Epistaxis
1.8
21.4
398
2300
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.2
21.4
213
965
RS221
NOMESCO Finland
NA
3.0
21.3
126
428
69520
ICD-8 Finland
Erythematous condition, Erythema nodosum
10.6
21.3
41
39
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.0
21.3
287
1481
ZX110
NOMESCO Finland
Intracutaneous
10.0
21.2
42
42
F2680
NOMESCO Finland
NA
18.9
21.2
32
17
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
2.1
21.1
234
1113
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
3.4
21.0
103
306
T90
ICPC
Diabetes non-insulin dependent
1.4
21.0
1305
9965
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
20.9
2560
21595
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
3.6
20.9
94
261
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.1
20.9
116
378
FPE37
NOMESCO Finland
Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes
8.0
20.9
47
59
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.2
20.9
215
991
L01AA01
ATC
cyclophosphamide; systemic
7.0
20.8
51
73
N05CF01
ATC
zopiclone; oral
1.3
20.7
1923
15616
212
Kela drug reimbursment
Gout
2.9
20.7
125
430
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
9.0
20.5
43
48
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
20.5
2407
20184
XF402
NOMESCO Finland
ECG with work load test
1.5
20.5
651
4351
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
5.3
20.4
62
117
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
20.4
951
6894
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.6
20.4
586
3823
1XC02
NOMESCO Finland
NA
4.5
20.4
73
165
SPAT1325
SPAT
Vaccination
1.3
20.4
2005
16413
I50.1
ICD-10 Finland
Left ventricular failure
2.1
20.3
240
1175
A10AE04
ATC
insulin glargine; parenteral
1.6
20.3
563
3643
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
3.1
20.2
113
370
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.7
20.2
408
2417
C01BD01
ATC
amiodarone; systemic
2.4
20.2
173
731
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
5.2
20.1
62
119
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.3
20.1
184
804
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.9
20.0
286
1510
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
10.6
19.8
38
36
N05.9
ICD-10 Finland
Unspecified nephritic syndrome, unspecified
12.6
19.8
35
28
D81.2
ICD-10 Finland
Severe combined immunodeficiency [SCID] with low or normal B-cell numbers
+∞
19.8
19
*
B02.9
ICD-10 Finland
Zoster without complication
1.8
19.7
324
1794
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
3.8
19.7
84
223
R05FB02
ATC
cough suppressants and expectorants
1.3
19.7
2292
19167
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
8.0
19.6
44
55
ZX114
NOMESCO Finland
Intramuscular
3.0
19.5
116
396
N06AA09
ATC
amitriptyline; systemic
1.6
19.5
583
3839
J01.1
ICD-10 Finland
Acute frontal sinusitis
2.9
19.4
119
414
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
2.5
19.4
151
606
N06AX21
ATC
duloxetine; oral
1.5
19.2
641
4328
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.8
19.2
351
2015
H26.2
ICD-10 Finland
Complicated cataract
3.3
19.1
98
302
SPAT1153
SPAT
Removal of sutures
1.3
19.1
1903
15576
Z31.5
ICD-10 Finland
Genetic counselling
1.9
19.0
293
1589
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.5
18.9
154
631
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.4
18.9
92
273
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.4
18.8
163
692
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.4
18.8
163
692
A03
ICPC
Fever
1.4
18.8
913
6665
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.8
18.8
358
2085
D81.1
ICD-10 Finland
Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
+∞
18.8
18
*
D82.4
ICD-10 Finland
Hyperimmunoglobulin E [IgE] syndrome
+∞
18.8
18
*
D82.1
ICD-10 Finland
Di George syndrome
+∞
18.8
18
*
N082, D899
ICD-10 Finland
NA
+∞
18.8
18
*
2790C
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[DEFICIENTIA IMMUNOGLOBULINI ALIA]
+∞
18.8
18
*
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.5
18.7
647
4404
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
7.7
18.7
43
56
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
3.1
18.7
101
324
U14
ICPC
Kidney symptom/complaint
3.2
18.6
100
319
C02CA01
ATC
prazosin; oral
3.2
18.6
100
319
B07.9
ICD-10 Finland
Verruca simplex
2.1
18.6
216
1050
J01CF05
ATC
flucloxacillin; systemic
2.0
18.6
236
1188
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.9
18.6
258
1348
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
10.3
18.6
36
35
R01AD01
ATC
beclometasone; nasal
1.4
18.5
924
6774
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
7.6
18.5
43
57
1242
FHL
Bronchoscopy and transbronchial lung apia
38.5
18.5
23
6
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
18.4
967
7157
A06AD11
ATC
lactulose; oral
1.5
18.4
752
5308
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
8.7
18.3
39
45
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
3.0
18.3
107
362
R60.9
ICD-10 Finland
Oedema, unspecified
1.9
18.2
275
1484
A07EA06
ATC
budesonide; oral, local oral
2.1
18.1
215
1057
B01AB10
ATC
tinzaparin; parenteral
1.7
18.1
403
2456
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.8
18.1
308
1729
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
14.3
18.0
30
21
R02
ICPC
Shortness of breath/dyspnoea
1.5
17.9
659
4545
J02AC03
ATC
voriconazole; systemic
11.4
17.9
33
29
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
2.4
17.9
157
670
WX882
NOMESCO Finland
High dependency care
2.2
17.8
186
863
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.4
17.8
147
608
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
4.7
17.8
60
128
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
16.5
17.8
28
17
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
3.2
17.8
92
286
1243
FHL
Bronchoscopy and other therapeutic procedure
18.1
17.7
27
15
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
5.6
17.7
51
91
D82.2
ICD-10 Finland
Immunodeficiency with short-limbed stature
+∞
17.7
17
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.6
17.7
130
507
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.0
17.5
223
1126
XF600
NOMESCO Finland
Bloodpressure measurement
1.7
17.5
375
2262
AS4
HP
Physiological pacemaker insertion DDD (R)
3.2
17.3
90
281
E000001
ATC
NA
1.3
17.3
1180
9121
B01AF02
ATC
apixaban; oral
1.6
17.2
482
3122
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
8.1
17.2
38
47
K90.0
ICD-10 Finland
Coeliac disease
2.2
17.2
184
865
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
1.9
17.2
238
1244
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
8.4
17.1
37
44
M10.3
ICD-10 Finland
Gout due to impairment of renal function
6.3
17.1
45
72
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.5
17.1
544
3635
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.6
17.1
123
475
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.0
17.0
226
1159
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.8
17.0
312
1797
M10.0
ICD-10 Finland
Idiopathic gout
2.2
16.9
177
822
A28
ICPC
Limited function/disability NOS
1.4
16.8
735
5253
K02.1
ICD-10 Finland
Caries of dentine
1.2
16.8
3589
32043
J06BA02
ATC
immunoglobulins, normal human, for intravascular adm.; systemic
+∞
16.7
16
*
D80.4
ICD-10 Finland
Selective deficiency of immunoglobulin M [IgM]
+∞
16.7
16
*
187
Kela drug reimbursment
MPA
35.1
16.6
21
6
ZYC01
NOMESCO Finland
Remote contact by phone
1.8
16.6
269
1484
FM1DM
NOMESCO Finland
Heart very extensive MRI examination with 3 Tesla magnet
15.0
16.6
27
18
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.7
16.6
367
2233
JN4DR
NOMESCO Finland
Whole body metabolic PET with CT
9.7
16.6
33
34
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.0
16.5
218
1116
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
11.6
16.5
30
26
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.6
16.5
486
3187
H22.1
ICD-10 Finland
Iridocyclitis in other diseases classified elsewhere
23.1
16.4
23
10
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
16.4
732
5252
AS8
HP
Physiological arrhythmia pacemaker insertionDDD (R) S
9.0
16.4
34
38
TQW80
NOMESCO Finland
Local dermatologic skincare
2.2
16.3
166
764
SPAT1229
SPAT
Assessment of need for aid
1.6
16.3
422
2680
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
16.2
1418
11359
G51.0
ICD-10 Finland
Bell palsy
2.2
16.2
159
718
AN1
HP
Coronary angiography
1.5
16.2
606
4197
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
3.7
16.2
70
190
TQW99
NOMESCO Finland
Other minor procedure on skin
1.8
16.2
282
1596
GX1K5
NOMESCO Finland
Diffusion capacity
8.8
16.1
34
39
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
2.5
16.0
129
529
G44.2
ICD-10 Finland
Tension-type headache
1.4
16.0
743
5370
R06AE09
ATC
levocetirizine; oral
1.4
16.0
848
6280
A10AE05
ATC
insulin detemir; parenteral
1.7
15.9
325
1933
D07AB08
ATC
desonide; topical
1.5
15.9
597
4137
A41.8
ICD-10 Finland
Other specified sepsis
2.8
15.8
104
381
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
2.7
15.8
111
422
R03DC01
ATC
zafirlukast; oral
2.7
15.8
106
391
NHQ40
NOMESCO Finland
Amputation of toe
2.9
15.8
98
346
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.5
15.8
600
4167
GD1CG
NOMESCO Finland
Extensive examination of lungs and pleura with high intensity magnet
14.5
15.8
26
18
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.5
15.7
478
3159
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
3.0
15.7
88
291
J01.4
ICD-10 Finland
Acute pansinusitis
3.8
15.7
65
170
R01AD05
ATC
budesonide; nasal
1.6
15.7
467
3070
Z99.2
ICD-10 Finland
Dependence on renal dialysis
11.2
15.7
29
26
N02.9
ICD-10 Finland
Recurrent and persistent haematuria, unspecified
15.7
15.7
25
16
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
7.3
15.7
37
51
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.3
15.6
145
639
D82.8
ICD-10 Finland
Immunodeficiency associated with other specified major defects
+∞
15.6
15
*
N00.9
ICD-10 Finland
Acute nephritic syndrome, Unspecified
12.9
15.6
27
21
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.9
15.6
243
1323
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
1.9
15.5
217
1139
C10AC01
ATC
colestyramine; oral
2.2
15.5
160
743
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.4
15.4
129
541
I51.4
ICD-10 Finland
Myocarditis, unspecified
4.5
15.4
54
121
GDA10
NOMESCO Finland
Biopsy of lung
8.9
15.4
32
36
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.1
15.4
179
876
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.2
15.3
156
719
R04.2
ICD-10 Finland
Haemoptysis
2.0
15.3
187
934
E87.5
ICD-10 Finland
Hyperkalaemia
2.8
15.2
98
353
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
3.7
15.2
65
175
WX872
NOMESCO Finland
Intensive care
1.8
15.2
279
1606
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.6
15.2
353
2180
FPG96
NOMESCO Finland
Other implantation of permanent cardioverter-defibrillator
5.5
15.2
44
80
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.2
15.2
153
703
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.8
15.2
284
1644
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
4.9
15.1
49
101
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
3.4
15.1
73
217
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.9
15.1
219
1166
Z2445
NOMESCO Finland
Psychologist
1.8
15.0
242
1335
UDM02
NOMESCO Finland
Sinoscopy
2.2
15.0
146
660
C08CA05
ATC
nifedipine; systemic
1.7
15.0
334
2040
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.4
14.9
122
504
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
2.6
14.9
109
425
R11
ICD-10 Finland
Nausea and vomiting
1.6
14.9
429
2802
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
14.9
1176
9277
7151
FHL
Kidney transplantation
12.4
14.8
26
21
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
14.8
819
6110
A07EC02
ATC
mesalazine; oral, rectal
1.7
14.7
322
1955
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.6
14.7
345
2135
R06AX27
ATC
desloratadine; oral
1.3
14.7
1590
13081
A12BA01
ATC
potassium chloride; oral
1.9
14.7
226
1228
WX720
NOMESCO Finland
Own respiration
1.9
14.7
226
1228
N03.0
ICD-10 Finland
Chronic nephritic syndrome, minor glomerular abnormality
13.2
14.7
25
19
Z94.2
ICD-10 Finland
Lung transplant status
9.7
14.6
29
30
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
3.1
14.6
78
250
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
14.6
700
5086
N02.8
ICD-10 Finland
Recurrent and persistent haematuria, other
+∞
14.6
14
*
M63.3*D86.8
ICD-10 Finland
Myositis in sarcoidosis
+∞
14.6
14
*
H57.1
ICD-10 Finland
Ocular pain
2.0
14.5
188
959
X57
ICD-10 Finland
Unspecified privation
2.3
14.5
133
585
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.3
14.5
129
558
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
4.6
14.5
49
106
SPAT1310
SPAT
Counselling related to known health issue
1.3
14.5
1864
15656
E86
ICD-10 Finland
Volume depletion
2.3
14.4
128
552
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.7
14.4
317
1928
A07AA09
ATC
vancomycin; oral
2.9
14.4
86
298
H65.3
ICD-10 Finland
Chronic mucoid otitis media
2.4
14.4
125
534
UDC00
NOMESCO Finland
Ear microscopy
1.6
14.4
399
2581
R81
ICPC
Pneumonia
2.0
14.3
182
922
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.4
14.3
618
4405
I44.0
ICD-10 Finland
Atrioventricular block, first degree
3.0
14.3
82
275
FM1CN
NOMESCO Finland
Heart perfusion isotope imaging at rest
27.2
14.2
19
7
M08.2
ICD-10 Finland
Juvenile arthritis with systemic onset
27.2
14.2
19
7
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
14.2
1633
13525
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
3.3
14.2
71
217
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
8.2
14.2
31
38
602
Kela drug reimbursment
Children's severe malnutrition
6.3
14.2
37
59
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
2.6
14.1
98
373
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
2.0
14.1
171
852
WW409
NOMESCO Finland
Other aferesis
7.0
14.0
34
49
L28
ICPC
Limited function/disability (L)
1.4
14.0
796
5962
C10AA05
ATC
atorvastatin; oral
1.2
13.9
2142
18346
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
5.0
13.9
44
89
N05BA01
ATC
diazepam; systemic, rectal
1.4
13.9
742
5495
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.3
13.9
1602
13270
H53.1
ICD-10 Finland
Subjective visual disturbances
1.6
13.9
343
2154
N25.0
ICD-10 Finland
Renal osteodystrophy
7.5
13.9
32
43
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.0
13.9
178
905
5BA08
NOMESCO Finland
NA
4.5
13.8
48
107
J01DC02
ATC
cefuroxime; systemic
1.6
13.8
331
2063
B02AA02
ATC
tranexamic acid; systemic
1.4
13.8
812
6115
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.2
13.8
138
633
TFP00
NOMESCO Finland
Temporary use of transvenous or epicardial pacemaker
3.4
13.8
66
196
58200
ICD-8 Finland
Chronic nephritis, Cum uraemia
23.8
13.8
19
8
TGW99
NOMESCO Finland
Other minor procedure in thoracic surgery
8.1
13.7
30
37
A10BA02
ATC
metformin; oral
1.3
13.7
1509
12427
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.7
13.7
298
1805
H65.2
ICD-10 Finland
Chronic serous otitis media
2.9
13.7
82
285
ZZA00
NOMESCO Finland
Split skin graft
2.1
13.7
161
790
J01DA08
ATC
[U] cefaclor; oral
1.4
13.7
578
4102
E000006
ATC
NA
1.6
13.6
389
2536
J33.8
ICD-10 Finland
Other polyp of sinus
2.2
13.6
134
610
L17
ICPC
Foot/toe symptom/complaint
1.3
13.6
1416
11581
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
2.3
13.5
128
571
D84.12
ICD-10 Finland
Hereditary angioedema type II
+∞
13.5
13
*
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.0
13.5
182
944
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.4
13.5
735
5462
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
13.5
707
5218
RS222
NOMESCO Finland
NA
2.8
13.4
87
316
XA800
NOMESCO Finland
Neuropsychological investigation
1.7
13.4
250
1451
XG466
NOMESCO Finland
Sleep oxymetry
1.9
13.3
195
1043
J06.80
ICD-10 Finland
Continuously repeating infections of a child
21.2
13.3
19
9
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.8
13.3
235
1340
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
4.2
13.3
50
121
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.6
13.3
314
1949
Z71.8
ICD-10 Finland
Other specified counselling
1.3
13.3
1343
10939
H05BX02
ATC
paricalcitol; systemic
9.7
13.2
26
27
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.7
13.2
255
1494
L03AA13
ATC
pegfilgrastim; parenteral
1.9
13.1
203
1106
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.5
13.1
98
388
KBV00
NOMESCO Finland
Insertion of stent into ureter
3.7
13.1
56
152
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
3.0
13.0
75
253
J33.0
ICD-10 Finland
Polyp of nasal cavity
2.0
13.0
161
809
R4120
NOMESCO Finland
Occupational therapy
1.6
13.0
351
2253
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
10.9
13.0
24
22
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
10.9
13.0
24
22
S01GX01
ATC
cromoglicic acid; ophthalmic
1.3
13.0
1121
8939
N17.8
ICD-10 Finland
Other acute renal failure
3.0
12.9
74
248
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.3
12.9
1320
10764
R01AD11
ATC
triamcinolone; nasal
1.5
12.8
479
3316
381
Kela drug reimbursment
Combination product containing sacubitril and valsartan
3.9
12.8
52
135
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
6.1
12.8
34
56
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.4
12.8
61
181
R01BA52
ATC
pseudoephedrine, combinations; oral
1.2
12.8
1852
15732
UJF02
NOMESCO Finland
Peroral enteroscopy
4.0
12.8
50
126
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
6.6
12.7
32
49
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.6
12.7
356
2308
J01CF02
ATC
cloxacillin; systemic
2.1
12.7
135
635
A01AB04
ATC
amphotericin B; local oral
1.7
12.7
258
1535
5AB14
NOMESCO Finland
NA
7.2
12.7
30
42
K65.8
ICD-10 Finland
Other peritonitis
7.2
12.7
30
42
EBA10
NOMESCO Finland
Surgical removal of tooth
1.4
12.7
621
4527
A10BH01
ATC
sitagliptin; oral
1.5
12.7
504
3529
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.7
12.7
249
1466
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
3.1
12.7
67
215
A05AA02
ATC
ursodeoxycholic acid; oral
2.4
12.7
106
448
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.6
12.7
301
1872
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.7
12.6
283
1733
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
3.6
12.6
56
157
N30.0
ICD-10 Finland
Acute cystitis
1.4
12.6
697
5191
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.4
12.6
697
5192
ZX131
NOMESCO Finland
Intrathecal
15.4
12.6
20
13
G03.9
ICD-10 Finland
Meningitis, unspecified
6.4
12.6
32
50
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
2.9
12.6
73
249
C09DX04
ATC
valsartan and sacubitril; oral
3.5
12.6
57
163
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
5.0
12.5
39
78
L95.8
ICD-10 Finland
Other vasculitis limited to skin
6.1
12.5
33
54
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
12.5
598
4342
A03FA02
ATC
cisapride; oral, rectal
1.5
12.5
399
2670
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
4.1
12.5
48
119
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
3.4
12.4
60
180
R06AX22
ATC
ebastine; oral
1.3
12.4
964
7569
L57.0
ICD-10 Finland
Actinic keratosis
1.5
12.4
461
3186
7910X
ICD-9 Finland
Nonspecific findings on examination of urine, Proteinuria[PROTEINURIA NUD]
9.3
12.4
25
27
GD2SN
NOMESCO Finland
Lung ventilation SPECT
3.6
12.4
54
149
G53.2
ICD-10 Finland
Multiple cranial nerve palsies in sarcoidosis
130.2
12.4
13
*
A10BJ06
ATC
semaglutide; parenteral
1.9
12.4
189
1025
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
12.4
3293
29685
XPX08
NOMESCO Finland
Intraoperative flow measurement
3.5
12.4
57
165
XQ848
NOMESCO Finland
Dermatological photography
2.1
12.4
145
714
SPAT1254
SPAT
Administration of medicine
1.4
12.4
759
5752
58399
ICD-8 Finland
Nephritis, unqualified
7.6
12.4
28
37
M54.5
ICD-10 Finland
Low back pain
1.2
12.3
1905
16284
I15.0
ICD-10 Finland
Renovascular hypertension
4.9
12.3
39
80
J32.1
ICD-10 Finland
Chronic frontal sinusitis
4.2
12.3
45
107
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.6
12.2
314
1993
R55
ICD-10 Finland
Syncope and collapse
1.4
12.2
546
3916
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.1
12.2
136
655
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
1.9
12.2
167
874
R75
ICPC
Sinusitis acute/chronic
1.7
12.1
235
1378
H47.1
ICD-10 Finland
Papilloedema, unspecified
4.4
12.1
43
99
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.4
12.1
560
4043
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
2.0
12.1
152
770
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
3.2
12.1
62
195
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.2
12.1
124
578
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.9
12.0
180
970
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
12.0
149
750
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
3.3
12.0
60
185
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
1.7
12.0
227
1325
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
12.0
2241
19522
L04AB04
ATC
adalimumab; parenteral
2.2
12.0
117
531
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.4
12.0
581
4233
N06.9
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, unspecified
7.2
12.0
28
39
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.1
11.9
141
694
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
11.9
70
241
RK110
NOMESCO Finland
NA
3.3
11.9
59
181
3025
Kela drug reimbursment
Calcium carbonate
5.9
11.9
32
54
SPAT1301
SPAT
No procedures
1.2
11.9
1809
15425
NH1AD
NOMESCO Finland
Ankle and foot CT
2.2
11.9
122
568
A07EC01
ATC
sulfasalazine; oral, rectal
1.5
11.9
448
3107
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
3.9
11.9
48
125
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
3.1
11.9
64
209
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
11.8
1473
12287
E66.9
ICD-10 Finland
Obesity, unspecified
1.8
11.8
192
1067
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.5
11.8
424
2909
J96.1
ICD-10 Finland
Chronic respiratory failure
2.4
11.8
102
437
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
11.7
11.8
21
18
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
3.3
11.8
57
172
Z94.1
ICD-10 Finland
Heart transplant status
5.8
11.7
32
55
2AX04
NOMESCO Finland
NA
10.5
11.7
22
21
C83.1
ICD-10 Finland
Mantle cell lymphoma
4.8
11.7
38
80
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
11.7
157
817
WW400
NOMESCO Finland
Plasmaferesis
6.3
11.6
30
48
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.9
11.6
161
847
KAS40
NOMESCO Finland
Excision of transplanted kidney
30.0
11.6
15
5
JN6AD
NOMESCO Finland
CT of torso and neck
2.7
11.6
78
293
H40.4
ICD-10 Finland
Glaucoma secondary to eye inflammation
7.7
11.6
26
34
I42.0
ICD-10 Finland
Dilated cardiomyopathy
2.0
11.6
146
742
D02AE01
ATC
carbamide; topical
1.5
11.6
379
2552
NH3EA
NOMESCO Finland
Feet X-ray examination with load
2.1
11.5
125
597
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.4
11.5
98
418
M05BX04
ATC
denosumab; parenteral
1.7
11.5
233
1388
Z01.9
ICD-10 Finland
Special examination, unspecified
1.6
11.5
297
1887
5188X
ICD-9 Finland
Other diseases of lung
11.1
11.5
21
19
WX725
NOMESCO Finland
Noninvasive ventilation
1.6
11.5
263
1620
K07.60
ICD-10 Finland
Snapping jaw
1.7
11.5
253
1542
FPH10
NOMESCO Finland
Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator
7.1
11.5
27
38
XG460
NOMESCO Finland
Short time oxymetry
2.5
11.5
91
374
M31.1
ICD-10 Finland
Thrombotic microangiopathy
9.2
11.5
23
25
3XA02
NOMESCO Finland
NA
9.2
11.5
23
25
D81.3
ICD-10 Finland
Adenosine deaminase [ADA] deficiency
+∞
11.5
11
*
Q87.06
ICD-10 Finland
Velocardiofacial syndrome
+∞
11.5
11
*
E000002
ATC
NA
1.4
11.5
615
4560
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.8
11.4
187
1042
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
1.9
11.4
163
866
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
1.9
11.4
155
810
XCK00
NOMESCO Finland
Perimetry
1.5
11.4
353
2344
C83.00
ICD-10 Finland
Lymphocytic lymphoma
6.7
11.4
28
42
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
3.6
11.4
49
135
D07AA02
ATC
hydrocortisone; topical
1.3
11.4
742
5678
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
3.0
11.4
63
210
B28
ICPC
Limited function/disability (B)
4.9
11.4
36
74
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
2.5
11.4
85
340
WZA90
NOMESCO Finland
Other doctors statement
1.3
11.4
1293
10665
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
11.4
1146
9317
CFA20
NOMESCO Finland
Biopsy of conjunctiva
6.3
11.3
29
46
M13.0
ICD-10 Finland
Polyarthritis, unspecified
2.6
11.3
80
309
XX3DW
NOMESCO Finland
Time consuming IT work
1.4
11.3
553
4032
49300
ICD-8 Finland
Asthma, bronchiale
2.0
11.3
137
685
L01XE27
ATC
[U] ibrutinib; oral
11.8
11.3
20
17
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
1.9
11.3
164
877
Z01.2
ICD-10 Finland
Dental examination
1.2
11.3
2470
21812
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
35.1
11.3
14
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.5
11.2
348
2311
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
1.8
11.2
201
1153
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
1.9
11.2
153
802
R06.8
ICD-10 Finland
Other and unspecified abnormalities of breathing
2.5
11.2
86
349
N28.9
ICD-10 Finland
Disorder of kidney and ureter, unspecified
5.3
11.1
33
63
L04AA13
ATC
leflunomide; oral
2.0
11.1
148
765
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
11.1
3434
31260
A02BA03
ATC
famotidine; systemic
1.7
11.1
206
1196
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.1
11.1
119
567
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
2.9
11.1
66
231
R03BC03
ATC
nedocromil; inhalant
1.5
11.0
383
2611
JAL10
NOMESCO Finland
Laparotomy and removal of foreign body
8.0
11.0
24
30
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.4
11.0
611
4556
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
5.2
11.0
33
64
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
8.5
11.0
23
27
FPJ24
NOMESCO Finland
Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes
8.5
11.0
23
27
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.1
11.0
115
540
R06.5
ICD-10 Finland
Mouth breathing
1.4
10.9
485
3473
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.3
10.9
99
434
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
10.9
1035
8342
C10AA01
ATC
simvastatin; oral
1.2
10.9
2365
20850
C10AA03
ATC
pravastatin; oral
1.5
10.9
346
2313
5820A
ICD-9 Finland
Chronic glomerulonephritis, With lesion of proliferative glomerulonephritis[GLOMERULONEPHRITIS CHRONICA PROLIF,EI NEFR SDR]
43.4
10.9
13
*
JN4CD
NOMESCO Finland
Very extensive body CT
1.7
10.9
206
1203
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.4
10.9
93
396
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
2.9
10.9
63
215
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
1.8
10.9
189
1074
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
1.8
10.9
195
1122
T78.4
ICD-10 Finland
Allergy, unspecified
1.7
10.9
240
1467
S01BC03
ATC
diclofenac; ophthalmic
2.0
10.9
135
680
K59.1
ICD-10 Finland
Functional diarrhoea
1.6
10.8
258
1607
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.5
10.8
392
2699
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
10.8
3570
32650
EB1WA
NOMESCO Finland
NA
3.1
10.8
56
179
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
4.1
10.8
40
97
K29.7
ICD-10 Finland
Gastritis, unspecified
1.8
10.8
181
1019
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.5
10.8
394
2718
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
2.7
10.8
69
253
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.3
10.7
1154
9447
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
3.5
10.7
49
142
M01AE02
ATC
naproxen; oral, rectal
1.2
10.7
3529
32251
GD1UN
NOMESCO Finland
Lung circulation SPECT
3.5
10.7
48
137
JAK03
NOMESCO Finland
Laparotomy and peritoneal irrigation
9.6
10.7
21
22
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
5.4
10.7
31
58
TKA00
NOMESCO Finland
Needle biopsy of kidney or pelvis of kidney
21.5
10.7
15
7
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.6
10.6
267
1685
U88
ICPC
Glomerulonephritis/nephrosis
12.9
10.6
18
14
L88
ICPC
Rheumatoid/seropositive arthritis
1.7
10.6
203
1191
C03AA03
ATC
hydrochlorothiazide; oral
1.4
10.6
480
3452
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.3
10.6
687
5249
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
2.8
10.6
66
236
HA1AA
NOMESCO Finland
X-ray mammography
1.5
10.6
377
2585
TFP20
NOMESCO Finland
Cardiodefibrillation
1.5
10.5
362
2462
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
10.5
584
4354
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.2
10.5
102
464
D59.9
ICD-10 Finland
Acquired haemolytic anaemia, unspecified
8.5
10.5
22
26
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
8.5
10.5
22
26
H15.1
ICD-10 Finland
Episcleritis
2.4
10.5
89
381
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.3
10.5
721
5556
J15.8
ICD-10 Finland
Other bacterial pneumonia
3.4
10.5
49
145
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.5
10.5
320
2123
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.6
10.5
300
1962
XF409
NOMESCO Finland
Other special ECG
3.5
10.4
47
135
E66.00
ICD-10 Finland
Metabolic syndrome
1.6
10.4
298
1946
B06AC05
ATC
lanadelumab; parenteral
+∞
10.4
10
*
B06AC01
ATC
c1-inhibitor, plasma derived; parenteral
+∞
10.4
10
*
2790A
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[AGAMMAGLOBULINAEMIA (BRUTON)]
+∞
10.4
10
*
D82.9
ICD-10 Finland
Immunodeficiency associated with major defect, unspecified
+∞
10.4
10
*
D80.5
ICD-10 Finland
Immunodeficiency with increased immunoglobulin M [IgM]
+∞
10.4
10
*
H53.2
ICD-10 Finland
Diplopia
1.8
10.4
163
898
S76
ICPC
Skin infection other
1.6
10.4
255
1605
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.8
10.4
183
1047
D02AX
ATC
Other emollients and protectives
1.8
10.4
181
1031
NF1AA
NOMESCO Finland
Hip X-ray examination
1.4
10.4
420
2956
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
3.5
10.4
47
136
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.1
10.3
109
516
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
12.0
10.3
18
15
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.1
10.3
115
555
390
Kela drug reimbursment
Ibrutinib
8.2
10.3
22
27
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
3.3
10.3
50
153
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
2.9
10.2
61
214
WX400
NOMESCO Finland
Inhalation anesthesy
1.6
10.2
242
1506
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.2
10.2
1716
14744
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
3.9
10.2
40
102
GDG10
NOMESCO Finland
Bilateral transplantation of lung
9.5
10.2
20
21
E87.6
ICD-10 Finland
Hypokalaemia
1.8
10.2
159
872
4059B
ICD-9 Finland
Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]
23.4
10.2
14
6
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
1.9
10.2
153
829
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.2
10.2
51
159
WX202
NOMESCO Finland
Supraclavicular plexus blockade
2.4
10.2
84
355
D68.8
ICD-10 Finland
Other specified coagulation defects
2.8
10.2
62
221
E83.51
ICD-10 Finland
Hypocalcemia
3.5
10.2
46
133
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.6
10.1
249
1565
SBA10
NOMESCO Finland
Measurement of excretion of saliva
2.8
10.1
64
232
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
3.8
10.1
41
108
ZXE40
NOMESCO Finland
More than seven and less than nine hours
1.9
10.1
134
697
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
10.1
4035
37400
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.6
10.1
266
1706
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
10.1
2351
20833
WX610
NOMESCO Finland
Patient controlled analgesia
3.5
10.1
45
129
WW300
NOMESCO Finland
Transfer of autologic stem cells
4.0
10.0
39
99
K11.2
ICD-10 Finland
Sialoadenitis
1.8
10.0
169
953
KH1AD
NOMESCO Finland
CT of urinary organs
1.8
10.0
171
969
H26.4
ICD-10 Finland
After-cataract
1.4
10.0
404
2844
6952A
ICD-9 Finland
Erythematous conditions, Erythema nodosum[ERYTHEMA NODOSUM ACUTUM]
10.0
10.0
19
19
YNB10
NOMESCO Finland
Collection of stem cells for transplant
6.4
10.0
25
39
A10BB12
ATC
glimepiride; oral
1.5
10.0
335
2270
D07XC01
ATC
betamethasone, combinations; topical
1.3
10.0
631
4801
M01AH02
ATC
rofecoxib; oral
1.3
10.0
701
5423
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.5
9.9
336
2281
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
2.9
9.9
59
207
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.5
9.9
359
2471
101
Kela drug reimbursment
Anterior pituitary hypofunction
3.1
9.9
52
168
H66.9
ICD-10 Finland
Otitis media, unspecified
1.5
9.9
289
1894
R74
ICPC
Upper respiratory infection acute
1.2
9.9
1558
13293
I49.5
ICD-10 Finland
Sick sinus syndrome
1.8
9.9
168
951
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
9.9
1448
12264
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
1.7
9.9
202
1210
R1250
NOMESCO Finland
Evaluation of functional capability
2.0
9.9
119
594
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.5
9.9
373
2592
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
1.9
9.9
130
673
WX780
NOMESCO Finland
Remote monitoring CPAP
1.7
9.9
215
1309
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.6
9.9
273
1768
J01GB01
ATC
tobramycin; inhalant, parenteral
16.7
9.9
15
9
H10.4
ICD-10 Finland
Chronic conjunctivitis
2.9
9.9
58
202
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
3.9
9.8
39
101
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
3.3
9.8
47
142
N06AX11
ATC
mirtazapine; oral
1.2
9.8
1813
15714
K92.1
ICD-10 Finland
Melaena
1.6
9.8
247
1563
J01XB01
ATC
colistin; inhalant, parenteral
26.0
9.8
13
5
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
2.3
9.8
87
382
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
2.5
9.8
75
306
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
2.0
9.7
120
605
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
9.7
2295
20338
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
2.0
9.7
113
557
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
1.7
9.7
182
1062
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.5
9.7
277
1811
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
2.4
9.7
82
350
104
Kela drug reimbursment
Thyroid insufficiency
1.5
9.6
364
2527
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
55.1
9.6
11
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
2.2
9.6
93
422
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.3
9.6
632
4836
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.5
9.6
313
2108
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
3.4
9.6
45
134
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.8
9.6
167
953
TFP34
NOMESCO Finland
Electrophysiological investigation
1.8
9.6
156
872
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.2
9.6
90
404
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.3
9.6
780
6158
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
2.3
9.6
85
373
RJ425
NOMESCO Finland
NA
8.4
9.5
20
24
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
1.8
9.5
161
912
F45.8
ICD-10 Finland
Other somatoform disorders
1.5
9.5
332
2270
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
2.5
9.5
72
291
SPAT1097
SPAT
Recording of ECG
1.3
9.5
769
6068
XX3BW
NOMESCO Finland
NA
15.0
9.5
15
10
H30.1
ICD-10 Finland
Disseminated chorioretinal inflammation
15.0
9.5
15
10
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
1.9
9.5
133
704
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.7
9.5
182
1068
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
2.7
9.5
61
225
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
4.0
9.5
36
90
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
9.5
2621
23534
A10BK03
ATC
empagliflozin; oral
1.5
9.5
353
2444
S29
ICPC
Skin symptom/complaint other
1.3
9.4
884
7108
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.2
9.4
1107
9147
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
2.9
9.4
56
197
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
100.2
9.4
10
*
GEA96
NOMESCO Finland
Other mediastinoscopic procedure
100.2
9.4
10
*
304
Kela drug reimbursment
Dornase alfa
100.2
9.4
10
*
5828B
ICD-9 Finland
Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,NEFR SDR]
30.0
9.4
12
*
N03.5
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangiocapillary glomerulonephritis
17.5
9.4
14
8
N082, D8989
ICD-10 Finland
NA
+∞
9.4
9
*
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
2.7
9.4
60
221
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.7
9.3
200
1215
WX203
NOMESCO Finland
Infraclavicular plexus blockade
1.9
9.3
126
660
WX704
NOMESCO Finland
Intubation
1.4
9.3
377
2656
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.7
9.3
201
1221
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.4
9.3
510
3792
R00.1
ICD-10 Finland
Bradycardia, unspecified
1.8
9.3
149
829
1512
Kela drug reimbursment
Ibrutinib
8.7
9.3
19
22
5839X
ICD-9 Finland
Nephritis and nephropathy, not specified as acute or chronic, With unspecified pathological lesion in kidney
10.6
9.3
17
16
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
2.8
9.2
56
200
J45
ICD-10 Finland
Asthma
1.4
9.2
509
3790
SPAT1260
SPAT
Consultation of another employee
1.3
9.2
959
7811
H3603, E103
ICD-10 Finland
NA
2.5
9.2
68
272
L95
ICPC
Osteoporosis
1.8
9.2
141
771
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.6
9.2
241
1541
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
1.9
9.2
129
685
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.4
9.2
73
302
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
3.9
9.2
36
93
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
2.7
9.2
62
234
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
3.0
9.2
50
167
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
2.6
9.2
66
259
L29
ICPC
Musculoskeletal sympt/complt other
1.4
9.1
369
2600
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.7
9.1
199
1213
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
9.1
130
694
R06AX13
ATC
loratadine; oral
1.3
9.1
817
6532
J01FA01
ATC
erythromycin; systemic
1.3
9.1
752
5948
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.3
9.1
695
5439
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
2.1
9.1
95
450
Z50.1
ICD-10 Finland
Other physical therapy
1.5
9.1
281
1872
C09CA07
ATC
telmisartan; oral
1.4
9.1
364
2562
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
3.6
9.1
39
109
B00.19
ICD-10 Finland
Other vesicular dermatitis caused by the herper simplex virus
3.8
9.1
36
94
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.4
9.1
509
3803
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
1.6
9.1
205
1262
K50.8
ICD-10 Finland
Other Crohn disease
2.2
9.0
87
397
J20.0
ICD-10 Finland
Acute bronchitis due to Mycoplasma pneumoniae
3.1
9.0
47
152
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
2.6
9.0
65
255
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
5.6
9.0
25
45
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
5.6
9.0
25
45
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
2.8
9.0
57
207
L01BB05
ATC
fludarabine; systemic
7.0
9.0
21
30
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
3.5
9.0
40
115
C08CA03
ATC
isradipine; systemic
2.5
9.0
69
282
B29
ICPC
Lymph/immune mech sympt/complt other
3.9
9.0
35
90
N06AX16
ATC
venlafaxine; oral
1.3
9.0
741
5862
B03BA03
ATC
hydroxocobalamin; parenteral
1.5
9.0
269
1780
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
2.3
8.9
80
351
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.4
8.9
420
3043
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.2
8.9
2902
26360
RS121
NOMESCO Finland
NA
3.2
8.9
44
137
KAS96
NOMESCO Finland
Other transplantation of kidney or related procedure
18.6
8.9
13
7
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
8.9
2906
26397
I89.9
ICD-10 Finland
Noninfective disorder of lymphatic vessels and lymph nodes, unspecified
7.4
8.9
20
27
ZX100
NOMESCO Finland
Oral
2.3
8.9
81
362
K03.64
ICD-10 Finland
Dental calculus supragingival
1.2
8.9
1563
13467
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
1.8
8.9
138
761
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.4
8.9
354
2489
J05AH02
ATC
oseltamivir; oral
3.0
8.8
48
160
DPA30
NOMESCO Finland
Sphenotomy
3.2
8.8
43
133
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
3.8
8.8
35
92
J32.8
ICD-10 Finland
Other chronic sinusitis
3.7
8.8
36
97
GX1D5
NOMESCO Finland
Flow volume spirometry
10.7
8.8
16
15
D50.8
ICD-10 Finland
Other iron deficiency anaemias
2.4
8.8
73
309
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
5.1
8.7
26
51
RJ414
NOMESCO Finland
NA
5.1
8.7
26
51
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
2.8
8.7
52
184
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
5.9
8.7
23
39
S01BA07
ATC
fluorometholone; ophthalmic (corticosteroids, plain)
2.1
8.7
94
450
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
4.0
8.7
33
83
DHB50
NOMESCO Finland
Turbinoplasty
1.8
8.7
146
826
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
1.7
8.7
157
909
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.6
8.7
227
1452
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
1.9
8.7
118
619
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
4.2
8.6
31
74
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
4.8
8.6
27
56
C08DA01
ATC
verapamil; systemic
1.6
8.6
201
1250
F2682
NOMESCO Finland
NA
6.6
8.6
21
32
ZX197
NOMESCO Finland
NA
7.6
8.6
19
25
K31.7
ICD-10 Finland
Polyp of stomach and duodenum
4.1
8.6
32
79
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
2.8
8.6
52
186
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
2.2
8.6
81
366
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
2.3
8.6
75
325
L28.0
ICD-10 Finland
Lichen simplex chronicus
2.6
8.6
59
226
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
5.0
8.6
26
52
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.0
8.6
105
530
M79.1
ICD-10 Finland
Myalgia
1.3
8.6
655
5126
RK320
NOMESCO Finland
NA
2.8
8.6
51
180
B01.9
ICD-10 Finland
Varicella without complication
3.9
8.6
33
84
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
3.0
8.6
47
158
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
1.9
8.6
126
682
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
3.6
8.6
36
99
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.3
8.6
652
5098
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.4
8.6
496
3724
78900
ICD-8 Finland
Abnormal urinary constituents of unspecified cause, Albuminuria
5.5
8.6
24
44
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.2
8.6
1245
10522
M10
ICD-10 Finland
Gout
1.6
8.6
205
1284
S01EC01
ATC
acetazolamide; systemic
2.0
8.5
109
560
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.4
8.5
424
3103
5829A
ICD-9 Finland
Chronic glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA NUD ,EI NEFR SDR]
16.3
8.5
13
8
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.5
8.5
267
1782
D07BC01
ATC
betamethasone and antiseptics; topical
1.3
8.5
641
5005
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
4.7
8.5
27
57
M03BC01
ATC
orphenadrine (citrate); systemic
1.2
8.5
1335
11370
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
2.6
8.5
59
229
A29
ICPC
General symptom/complaint other
1.3
8.5
544
4150
B99
ICPC
Blood/lymph/spleen disease other
3.7
8.5
35
95
S01FA04
ATC
cyclopentolate; ophthalmic
2.5
8.5
65
264
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
6.4
8.5
21
33
FPK00
NOMESCO Finland
Implantation of electrocardiograph with loop recorder
3.2
8.5
42
132
D06BX01
ATC
metronidazole; topical
1.3
8.4
532
4050
JF1BD
NOMESCO Finland
Very extensive small bowel CT
3.4
8.4
39
116
D01
ICPC
Abdominal pain/cramps general
1.3
8.4
528
4015
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
2.7
8.4
55
206
DPA20
NOMESCO Finland
Trephine of frontal sinus
6.0
8.4
22
37
N08.2*D65
ICD-10 Finland
Glomerular disorders in disseminated intravascular coagulation [defibrination syndrome]
90.2
8.4
9
*
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
8.4
4406
41402
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
3.8
8.4
33
86
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
4.3
8.4
29
67
RS224
NOMESCO Finland
NA
3.7
8.4
35
96
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.2
8.4
2396
21512
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.5
8.4
273
1843
TPX15
NOMESCO Finland
Removal of vascular injection port
3.3
8.4
39
117
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
3.3
8.4
39
117
H40.6
ICD-10 Finland
Glaucoma secondary to drugs
12.7
8.4
14
11
B81
ICPC
Anaemia vit B12/folate deficiency
1.7
8.3
178
1081
D83.2
ICD-10 Finland
Common variable immunodeficiency with autoantibodies to B- or T-cells
+∞
8.3
8
*
5829B
ICD-9 Finland
Chronic glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA NUD ,NEFR SDR]
+∞
8.3
8
*
N082, D890
ICD-10 Finland
NA
+∞
8.3
8
*
N082, Z940
ICD-10 Finland
NA
+∞
8.3
8
*
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.7
8.3
171
1027
M31.3
ICD-10 Finland
Wegener granulomatosis
4.0
8.3
31
77
R13
ICD-10 Finland
Dysphagia
1.5
8.3
314
2182
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
2.7
8.3
54
202
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
3.6
8.3
35
97
S01FA02
ATC
scopolamine; ophthalmic
2.6
8.3
57
219
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
4.6
8.3
27
59
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
1.9
8.3
121
654
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.6
8.3
202
1274
WX204
NOMESCO Finland
Axillary plexus blockaced
1.7
8.2
165
983
C09CA03
ATC
valsartan; oral
1.4
8.2
437
3235
ZXC50
NOMESCO Finland
Cryotherapy
1.8
8.2
142
811
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
1.8
8.2
125
685
N06AB04
ATC
citalopram; systemic
1.2
8.2
1181
9965
R5599
NOMESCO Finland
Other rehabilitation service
1.8
8.2
142
813
TEA00
NOMESCO Finland
Biopsy of lip
2.7
8.2
54
204
QDA10
NOMESCO Finland
Incision of skin of lower limb
2.9
8.2
48
168
FM2CE
NOMESCO Finland
NA
3.3
8.2
39
119
B05XA03
ATC
sodium chloride; parenteral
14.5
8.2
13
9
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
2.9
8.2
47
161
M01AG02
ATC
tolfenamic acid; oral, rectal
1.3
8.2
818
6629
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
4.2
8.2
29
69
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
2.9
8.1
48
169
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
2.2
8.1
75
336
R33
ICD-10 Finland
Retention of urine
1.4
8.1
336
2379
J04AB02
ATC
rifampicin; systemic
2.3
8.1
70
305
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
1.8
8.1
132
741
318
Kela drug reimbursment
Teriparatide
3.5
8.1
36
104
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
8.1
771
6208
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
1.7
8.1
148
860
WX723
NOMESCO Finland
CPAP therapy
1.6
8.1
186
1155
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
2.4
8.1
66
279
M14.8*L52
ICD-10 Finland
Arthropathy in erythema: nodosum
33.4
8.1
10
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
8.1
8.1
17
21
L04AA10
ATC
sirolimus; oral
11.7
8.1
14
12
A10BJ02
ATC
liraglutide; parenteral
1.8
8.0
127
704
2AA01
NOMESCO Finland
NA
22.0
8.0
11
5
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
2.5
8.0
60
244
R01BA51
ATC
phenylpropanolamine, combinations; oral
1.3
8.0
580
4510
WZA10
NOMESCO Finland
Long statement of health and health related matters
2.1
8.0
80
375
E21.1
ICD-10 Finland
Secondary hyperparathyroidism, not elsewhere classified
5.8
8.0
21
36
C01DA14
ATC
isosorbide mononitrate; oral
1.3
8.0
652
5151
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
1.5
7.9
236
1560
C08DB01
ATC
diltiazem; oral
1.5
7.9
228
1494
H20.8
ICD-10 Finland
Other iridocyclitis
4.0
7.9
30
76
D01AC03
ATC
econazole; topical
1.4
7.9
309
2164
H05AA02
ATC
teriparatide; parenteral
3.6
7.9
34
96
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.2
7.9
1370
11775
L14
ICPC
Leg/thigh symptom/complaint
1.4
7.9
366
2650
C90.0
ICD-10 Finland
Multiple myeloma
2.5
7.9
58
231
M79.7
ICD-10 Finland
Fibromyalgia
1.7
7.9
170
1037
C82.1
ICD-10 Finland
Follicular lymphoma grade II
3.2
7.9
39
123
S01ED51
ATC
timolol, combinations; ophthalmic
1.4
7.9
321
2267
6112
FHL
Installation of a peritoneal dialysis or lavage catheter in an operating room
13.0
7.9
13
10
M04AA03
ATC
febuxostat; oral
4.2
7.9
28
67
X58
ICD-10 Finland
Exposure to other specified factors
1.3
7.9
731
5870
SBA00
NOMESCO Finland
Microbiological examinations
1.8
7.9
131
740
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
2.0
7.9
97
493
G43.9
ICD-10 Finland
Migraine, unspecified
1.5
7.9
262
1778
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.3
7.8
715
5729
L20.0
ICD-10 Finland
Besnier prurigo
1.4
7.8
322
2276
A04
ICPC
Weakness/tiredness general
1.3
7.8
625
4921
C02EA02
ATC
NA
1.6
7.8
199
1267
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
3.9
7.8
30
77
-50
ICPC
Medication/prescr/renewal
1.6
7.8
207
1334
D72.1
ICD-10 Finland
Eosinophilia
3.6
7.8
33
92
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
8.4
7.8
16
19
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.3
7.8
762
6158
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
2.9
7.8
45
156
A08
ICPC
Swelling
1.6
7.7
192
1217
R00.2
ICD-10 Finland
Palpitations
1.4
7.7
350
2521
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
4.8
7.7
24
50
R49.01
ICD-10 Finland
Functional dysphonia
1.7
7.7
155
927
SPAT1104
SPAT
Monitoring of emergency patient
1.4
7.7
329
2344
R4130
NOMESCO Finland
Speech therapy
1.9
7.7
113
613
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
2.5
7.7
57
228
K12.10
ICD-10 Finland
Stomatitis NOS
3.3
7.7
37
114
K90.9
ICD-10 Finland
Intestinal malabsorption, unspecified
3.9
7.7
30
78
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.4
7.7
329
2347
ZZR00
NOMESCO Finland
Flap of skin
1.9
7.7
105
556
S21
ICPC
Skin texture symptom/complaint
1.3
7.7
609
4792
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
1.7
7.7
146
861
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
1.9
7.7
108
576
R52.9
ICD-10 Finland
Pain, unspecified
1.4
7.7
423
3156
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
2.4
7.7
63
267
PB1AC
NOMESCO Finland
Angiography of upper extremity with X-ray
7.4
7.7
17
23
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
1.5
7.7
283
1964
A10BK01
ATC
dapagliflozin; oral
1.5
7.6
222
1460
N05CD07
ATC
temazepam; oral
1.3
7.6
604
4749
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.5
7.6
237
1583
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.1
7.6
84
408
XX9XE
NOMESCO Finland
Other ultrasound examination
2.5
7.6
57
231
RJ420
NOMESCO Finland
NA
3.5
7.6
33
94
M35.7
ICD-10 Finland
Hypermobility syndrome
2.2
7.6
75
349
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
1.5
7.6
243
1635
H01AC01
ATC
somatropin; parenteral
3.8
7.6
30
79
XKD00
NOMESCO Finland
Uroflowmetry
1.3
7.6
737
5948
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.3
7.6
482
3675
XQ802
NOMESCO Finland
Epicutan test
1.6
7.6
203
1311
JAH01
NOMESCO Finland
Laparoscopy
1.5
7.6
226
1497
N18.3
ICD-10 Finland
Chronic kidney disease, stage 3
6.7
7.6
18
27
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.2
7.6
885
7306
B01AC04
ATC
clopidogrel; oral
1.3
7.5
731
5903
EMB10
NOMESCO Finland
Tonsillectomy
1.5
7.5
264
1811
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
10.0
7.5
14
14
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.5
7.5
240
1612
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
2.1
7.5
81
391
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
1.9
7.5
103
546
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
1.9
7.5
99
518
A01
ICPC
Pain general/multiple sites
1.4
7.5
371
2714
E23.03
ICD-10 Finland
Lack of ACTH
5.7
7.5
20
35
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
1.5
7.5
268
1847
N77.1*A60.0
ICD-10 Finland
Vaginitis, vulvitis and vulvovaginitis in herpesviral [herpes simplex] infection
4.3
7.5
26
61
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
1.6
7.5
205
1333
A01AB10
ATC
natamycin; local oral
1.7
7.5
133
767
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
3.4
7.5
34
101
R99
ICPC
Respiratory disease other
2.0
7.5
90
455
4224
FHL
Endonasal anthrostomy
2.4
7.5
59
246
GAA31
NOMESCO Finland
Thoracoscopy
4.1
7.5
27
66
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
2.9
7.4
43
149
288
Kela drug reimbursment
Febuxostat
4.0
7.4
28
71
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
3.7
7.4
30
81
ACC51
NOMESCO Finland
Release of median nerve
1.4
7.4
371
2723
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.4
7.4
411
3069
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
1.8
7.4
125
709
UJD02
NOMESCO Finland
Gastroscopy
1.5
7.4
231
1544
H26.02
ICD-10 Finland
Presenil cataract
1.7
7.4
143
847
L50.9
ICD-10 Finland
Urticaria, unspecified
1.6
7.4
178
1118
TK823
NOMESCO Finland
Peritoneal permeability analysis
13.3
7.4
12
9
XFE00
NOMESCO Finland
Epicardial ultrasonography
1.8
7.4
121
681
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
2.9
7.4
43
151
L40.0
ICD-10 Finland
Psoriasis vulgaris
1.5
7.4
214
1408
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.4
7.3
401
2987
R20.2
ICD-10 Finland
Paraesthesia of skin
1.4
7.3
332
2391
GD1AA
SPAT
NA
1.4
7.3
358
2617
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
2.0
7.3
82
403
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
7.3
1572
13764
D68.1
ICD-10 Finland
Hereditary factor XI deficiency
+∞
7.3
7
*
KBV10
NOMESCO Finland
Removal of stent from ureter
2.7
7.3
47
175
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.6
7.3
182
1155
J01CE08
ATC
benzathine benzylpenicillin; parenteral
2.5
7.3
55
225
E27.2
ICD-10 Finland
Addisonian crisis
10.8
7.3
13
12
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
6.8
7.3
17
25
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
2.4
7.3
58
244
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
1.8
7.3
111
612
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
2.3
7.3
62
271
N03AE01
ATC
clonazepam; systemic
1.4
7.3
289
2034
SDA02
NOMESCO Finland
Parodonthologic therapy
1.2
7.2
1823
16169
K50.9
ICD-10 Finland
Crohn disease, unspecified
2.1
7.2
81
396
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
1.9
7.2
99
526
D68.0
ICD-10 Finland
Von Willebrand disease
4.5
7.2
24
54
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
1.6
7.2
183
1165
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
2.0
7.2
90
460
T86.8
ICD-10 Finland
Failure and rejection of other transplanted organs and tissues
15.7
7.2
11
7
JAK01
NOMESCO Finland
Laparoscopic drainage of peritoneal cavity
15.7
7.2
11
7
H92.0
ICD-10 Finland
Otalgia
1.5
7.2
238
1612
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.5
7.2
202
1321
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
3.0
7.2
38
126
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
4.6
7.2
23
50
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
1.9
7.2
104
562
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
7.3
7.2
16
22
D01AC02
ATC
miconazole; topical
1.4
7.2
381
2826
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.4
7.2
398
2973
YNB20
NOMESCO Finland
Storage of stem cells for transplant
30.0
7.1
9
*
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
2.0
7.1
81
401
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
2.3
7.1
60
259
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
3.9
7.1
27
69
K01.0
ICD-10 Finland
Embedded teeth
2.1
7.1
80
391
I01.0
ICD-10 Finland
Acute rheumatic pericarditis
20.0
7.1
10
5
L01BB01
ATC
NA
4.8
7.1
22
46
NK6PA
NOMESCO Finland
Measurement of bone density from one location with X-ray
4.4
7.1
24
55
WNF00
NOMESCO Finland
Infection source and contact determination
3.3
7.1
33
100
H71
ICPC
Acute otitis media/myringitis
2.2
7.1
65
291
J35.0
ICD-10 Finland
Chronic tonsillitis
1.5
7.1
232
1567
DMB10
NOMESCO Finland
Radical maxillary antrotomy
3.2
7.1
35
111
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
7.9
7.1
15
19
DHA10
NOMESCO Finland
Biopsy of cavity of nose
2.5
7.1
50
197
H16.0
ICD-10 Finland
Corneal ulcer
1.5
7.1
235
1595
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.6
7.1
180
1150
T79.3
ICD-10 Finland
Post-traumatic wound infection, not elsewhere classified
2.1
7.1
73
347
GD1BG
NOMESCO Finland
MRI of lungs and pleura with high intensity magnet
12.0
7.1
12
10
Z85.6
ICD-10 Finland
Personal history of leukaemia
12.0
7.1
12
10
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
1.9
7.1
99
529
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
1.8
7.1
105
573
XX1XW
NOMESCO Finland
Extensive written report from radiologist
1.8
7.0
107
589
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
2.9
7.0
41
144
FPE40
NOMESCO Finland
Replacement of transvenous cardiac pacemaker electrode
3.6
7.0
29
80
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
1.9
7.0
91
474
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
2.3
7.0
59
254
SAA01
NOMESCO Finland
Simple examination of mouth
1.1
7.0
4456
42159
M148, L529
ICD-10 Finland
NA
10.0
7.0
13
13
H25.0
ICD-10 Finland
Senile incipient cataract
1.4
7.0
269
1883
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
2.0
7.0
84
424
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
2.0
7.0
84
424
C01AA05
ATC
digoxin; systemic
1.4
7.0
308
2212
RJ411
NOMESCO Finland
NA
3.0
7.0
38
129
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
1.5
7.0
244
1674
TQW40
NOMESCO Finland
Remowal of suture of skin
1.4
7.0
362
2672
N05BB01
ATC
hydroxyzine; systemic
1.4
7.0
313
2253
L12
ICPC
Hand/finger symptom/complaint
1.3
7.0
717
5832
A40.9
ICD-10 Finland
Streptococcal sepsis, unspecified
4.9
6.9
21
43
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.4
6.9
271
1903
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.2
6.9
860
7140
J04BA02
ATC
dapsone; oral
3.0
6.9
37
124
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
3.9
6.9
26
66
A10AE06
ATC
insulin degludec; parenteral
1.6
6.9
151
928
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
3.8
6.9
27
71
H01
ICPC
Ear pain/earache
1.3
6.9
520
4064
G04CA02
ATC
tamsulosin; oral
1.2
6.9
1023
8652
S01GX05
ATC
lodoxamide; ophthalmic
2.2
6.9
69
322
J37.0
ICD-10 Finland
Chronic laryngitis
1.6
6.9
154
953
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
2.4
6.9
55
230
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
5.4
6.9
19
35
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.3
6.9
462
3553
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.4
6.8
303
2177
J01CF01
ATC
dicloxacillin; systemic
2.7
6.8
44
163
R06.4
ICD-10 Finland
Hyperventilation
2.0
6.8
85
436
K06.18
ICD-10 Finland
Another gingival hyperplasia
3.8
6.8
27
72
TKC20
NOMESCO Finland
Catheterisation of bladder
1.4
6.8
326
2374
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.2
6.8
1477
12929
UJK12
NOMESCO Finland
Peroral cholangioscopy
4.8
6.8
21
44
306
Kela drug reimbursment
Erythropoietin and darbepoetin
4.3
6.8
23
53
-1
NOMESCO Finland
NA
1.2
6.8
1875
16733
N03.1
ICD-10 Finland
Chronic nephritic syndrome, focal and segmental glomerular lesions
8.2
6.8
14
17
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
2.2
6.8
63
284
JMA10
NOMESCO Finland
Transabdominal total splenectomy
2.9
6.8
37
126
121
Kela drug reimbursment
Severe hypofunction of sexual glands
1.9
6.8
99
537
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
1.9
6.8
99
537
R07.3
ICD-10 Finland
Other chest pain
1.3
6.8
461
3553
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.5
6.8
256
1784
N18
ICD-10 Finland
Chronic kidney disease
2.6
6.8
46
179
M02AA07
ATC
piroxicam; topical
1.2
6.8
2047
18391
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
9.3
6.8
13
14
LCA06
NOMESCO Finland
Biopsy of endometrium
1.3
6.8
577
4587
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
1.7
6.8
123
716
R96
ICPC
Asthma
1.3
6.8
418
3178
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
2.0
6.8
82
416
27510
ICD-8 Finland
Plasma protein abnormalities, Hypogammaglobulinaemia
40.1
6.8
8
*
QBA10
NOMESCO Finland
Incision of skin of trunk
2.3
6.7
60
266
NG4AA
NOMESCO Finland
Lower leg X-ray examination
1.6
6.7
144
881
I45.1
ICD-10 Finland
Other and unspecified right bundle-branch block
3.1
6.7
34
110
B05D
ATC
PERITONEAL DIALYTICS
16.7
6.7
10
6
N0832, E112
ICD-10 Finland
NA
16.7
6.7
10
6
N04.3
ICD-10 Finland
Nephrotic syndrome, diffuse mesangial proliferative glomerulonephritis
16.7
6.7
10
6
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
1.7
6.7
132
789
JAF10
NOMESCO Finland
Repair of umbilical hernia
1.8
6.7
112
637
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.4
6.7
282
2009
M01AH01
ATC
celecoxib; oral (coxibs)
1.2
6.7
949
7987
N02AC04
ATC
dextropropoxyphene; oral
1.6
6.7
168
1069
I42.1
ICD-10 Finland
Obstructive hypertrophic cardiomyopathy
3.3
6.7
31
94
RJ410
NOMESCO Finland
NA
3.3
6.7
31
94
4222
FHL
Endonasal etmoidectomy
2.6
6.7
44
167
S01XA18
ATC
ciclosporin; ophthalmic
3.0
6.7
35
116
M54.4
ICD-10 Finland
Lumbago with sciatica
1.2
6.7
851
7083
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
2.3
6.7
57
248
H43.1
ICD-10 Finland
Vitreous haemorrhage
1.8
6.7
115
657
H25.8
ICD-10 Finland
Other senile cataract
1.3
6.7
440
3375
J02AC02
ATC
itraconazole; systemic
1.2
6.7
960
8096
K78
ICPC
Atrial fibrillation/flutter
1.4
6.7
324
2367
J05AB09
ATC
famciclovir; oral
3.0
6.7
36
122
RS230
NOMESCO Finland
NA
3.1
6.7
34
111
R35
ICD-10 Finland
Polyuria
1.4
6.7
288
2061
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.2
6.7
763
6284
I42.2
ICD-10 Finland
Other hypertrophic cardiomyopathy
2.6
6.7
45
175
N05BA04
ATC
oxazepam; oral
1.2
6.6
1331
11573
I42.8
ICD-10 Finland
Other cardiomyopathies
3.3
6.6
31
95
C02DE10
ATC
NA
2.5
6.6
48
194
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.0
6.6
83
427
L30.3
ICD-10 Finland
Infective dermatitis
1.6
6.6
167
1067
J01EA01
ATC
trimethoprim; systemic
1.2
6.6
1289
11184
XCH00
NOMESCO Finland
Eye pressure measurement
1.5
6.6
184
1202
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
1.8
6.6
109
618
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
5.5
6.6
18
33
R93.8
ICD-10 Finland
Abnormal findings on diagnostic imaging of other specified body structures
3.2
6.6
32
101
01107
ICD-8 Finland
Pulmonary tuberculosis, Suspecta
4.6
6.6
21
46
J01MA01
ATC
ofloxacin; systemic
1.3
6.5
413
3146
I45.3
ICD-10 Finland
Trifascicular block
3.6
6.5
27
75
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.4
6.5
289
2076
N03AX11
ATC
topiramate; oral
1.7
6.5
119
693
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.4
6.5
247
1725
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.3
6.5
469
3645
M35.2
ICD-10 Finland
Behçet disease
10.0
6.5
12
12
K30
ICD-10 Finland
Functional dyspepsia
1.3
6.5
519
4088
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
2.6
6.5
46
181
5997A
ICD-9 Finland
Other disorders of urethra and urinary tract, Haematuria
3.4
6.5
29
86
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
3.4
6.5
29
86
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.5
6.5
189
1249
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
1.6
6.5
167
1070
I20.00
ICD-10 Finland
Unstable angina
1.7
6.5
131
789
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
2.3
6.5
56
247
J34.2
ICD-10 Finland
Deviated nasal septum
1.4
6.5
266
1888
A87.9
ICD-10 Finland
Viral meningitis, unspecified
2.8
6.5
39
142
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
1.5
6.4
240
1669
FPJ22
NOMESCO Finland
Revision of cardioverter-defibrillator with atrial and ventricular electrodes
5.3
6.4
18
34
R04
ICPC
Breathing problem other
1.6
6.4
162
1035
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
2.8
6.4
38
136
F45.0
ICD-10 Finland
Somatization disorder
3.1
6.4
32
103
NGQ20
NOMESCO Finland
Amputation of lower leg
3.1
6.4
32
103
N06.3
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, diffuse mesangial proliferative glomerulonephritis
69.9
6.4
7
*
E84.1
ICD-10 Finland
Cystic fibrosis with intestinal manifestations
69.9
6.4
7
*
I41.8*M05.3
ICD-10 Finland
Rheumatoid myocarditis
69.9
6.4
7
*
D82.0
ICD-10 Finland
Wiskott-Aldrich syndrome
69.9
6.4
7
*
2770A
ICD-9 Finland
Other and unspecified disorders of metabolism, Cystic fibrosis
69.9
6.4
7
*
T92
ICPC
Gout
1.9
6.4
88
469
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
2.1
6.4
64
302
A03CA02
ATC
clidinium and psycholeptics; oral
1.4
6.4
279
1999
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
2.0
6.4
77
389
RK250
NOMESCO Finland
NA
3.0
6.4
33
109
ZXF05
NOMESCO Finland
Interruption of procedure for other patient related reason
3.0
6.4
33
109
N04.89
ICD-10 Finland
Nephrotic syndrome, other
14.3
6.4
10
7
I47.1
ICD-10 Finland
Supraventricular tachycardia
1.5
6.4
197
1320
I49.1
ICD-10 Finland
Atrial premature depolarization
1.6
6.4
155
981
160
Kela drug reimbursment
exenatide
1.8
6.4
103
578
K05.11
ICD-10 Finland
Gingivitis (chronic) hyperplastic
3.4
6.4
28
82
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.2
6.4
758
6264
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
2.1
6.4
68
329
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.5
6.4
174
1134
81
HP
Angiography of the heart and coronary arteries
1.4
6.4
252
1775
SPAT1281
SPAT
Other administrative function
1.3
6.4
392
2975
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
2.0
6.4
79
405
H01.80
ICD-10 Finland
Prolonged inflammation in the edge of the eyelid
2.6
6.3
42
161
FPG30
NOMESCO Finland
Implantation of cardioverter-defibrillator with ventricular electrode
2.8
6.3
37
131
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
1.7
6.3
133
810
S01BC05
ATC
ketorolac; ophthalmic
1.6
6.3
170
1102
J01
ICD-10 Finland
Acute sinusitis
1.5
6.3
234
1625
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.2
6.3
1289
11225
CKC12
NOMESCO Finland
Photocoagulation of retina
1.5
6.3
202
1363
B00.9
ICD-10 Finland
Herpesviral infection, unspecified
3.1
6.3
31
99
A99
ICPC
Disease/condition unspecnature/site
1.3
6.3
378
2860
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
2.0
6.3
70
345
RJ521
NOMESCO Finland
NA
5.2
6.3
18
35
78930
ICD-8 Finland
Abnormal urinary constituents of unspecified cause, Haematuria
2.9
6.3
34
116
H05.0
ICD-10 Finland
Acute inflammation of orbit
5.9
6.3
16
27
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
1.6
6.3
168
1087
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
2.5
6.3
45
180
B59
ICD-10 Finland
Pneumocystosis
9.2
6.3
12
13
A86
ICD-10 Finland
Unspecified viral encephalitis
3.1
6.3
32
105
NFQ20
NOMESCO Finland
Amputation of femur
2.7
6.3
38
139
H3603, E113
ICD-10 Finland
NA
2.4
6.3
48
198
PBU99
NOMESCO Finland
Other repair after previous reconstruction of arteries of upper extremity
18.0
6.3
9
5
D59.3
ICD-10 Finland
Haemolytic-uraemic syndrome
18.0
6.3
9
5
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.1
6.3
69
337
N0839, D8980
ICD-10 Finland
NA
+∞
6.2
6
*
D84.14
ICD-10 Finland
C1 esterase inhibitor deficiency (C1-INH deficiency)
+∞
6.2
6
*
2798X
ICD-9 Finland
Disorders involving the immune mechanism, Other specified disorders involving the immune mechanism[MORBUS IMMUNOSYSTEMATIS ALIA DEFINITA]
+∞
6.2
6
*
D81.6
ICD-10 Finland
Major histocompatibility complex class I deficiency
+∞
6.2
6
*
N04BC05
ATC
pramipexole; oral
1.4
6.2
343
2562
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
1.7
6.2
113
660
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
1.9
6.2
82
429
3A006
NOMESCO Finland
NA
26.7
6.2
8
*
H30.8
ICD-10 Finland
Other chorioretinal inflammations
26.7
6.2
8
*
K50.0
ICD-10 Finland
Crohn disease of small intestine
2.0
6.2
76
389
WX213
NOMESCO Finland
Lower leg blockade
2.6
6.2
42
164
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
3.3
6.2
28
84
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
3.3
6.2
28
84
AS7
HP
Arrhythmia pacemaker insertion VVI (R) S
4.8
6.2
19
40
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
1.6
6.2
161
1036
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
7.0
6.2
14
20
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
2.1
6.2
65
314
H11.3
ICD-10 Finland
Conjunctival haemorrhage
1.5
6.2
170
1110
RS211
NOMESCO Finland
NA
3.5
6.2
26
74
51899
ICD-8 Finland
Bronchiectasis
5.0
6.2
18
36
XX9XW
NOMESCO Finland
NA
2.5
6.2
45
183
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
1.7
6.2
114
670
K76.9
ICD-10 Finland
Liver disease, unspecified
2.0
6.2
71
355
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.2
6.2
59
273
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.5
6.2
222
1537
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
1.8
6.1
92
507
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
1.8
6.1
92
507
N03.2
ICD-10 Finland
Chronic nephritic syndrome, diffuse membranous glomerulonephritis
6.3
6.1
15
24
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
6.3
6.1
15
24
D73.1
ICD-10 Finland
Hypersplenism
6.3
6.1
15
24
D01AE15
ATC
terbinafine; topical
1.4
6.1
328
2439
ASB
HP
Insertion of a biventricular physiological pacemaker DDD (R)
5.7
6.1
16
28
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
1.5
6.1
174
1143
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
2.4
6.1
47
194
S01ED01
ATC
timolol; ophthalmic
1.6
6.1
152
966
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
2.1
6.1
68
333
4660A
ICD-9 Finland
Acute bronchitis and bronchiolitis, Acute bronchitis
2.3
6.1
53
233
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.5
6.1
201
1365
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
1.9
6.1
81
425
M03BX02
ATC
tizanidine; oral
1.1
6.1
3881
36561
XF622
NOMESCO Finland
Measurement of minute volume of heart
3.4
6.1
27
80
UGC02
NOMESCO Finland
Rigid bronchoscopy
4.2
6.1
21
50
A09AA02
ATC
multienzymes (lipase, protease etc.)
1.8
6.1
93
515
D09
ICPC
Nausea
1.5
6.1
175
1153
XG413
NOMESCO Finland
Spirometry with oscillometry
4.6
6.1
19
41
DCW00
NOMESCO Finland
Removal of ventilating tube from tympanic membrane
12.5
6.1
10
8
4040
NOMESCO Finland
NA
12.5
6.1
10
8
A10BH02
ATC
vildagliptin; oral
1.8
6.1
93
516
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.4
6.1
281
2037
JKA20
NOMESCO Finland
Cholecystectomy
1.7
6.1
122
736
L04AB01
ATC
etanercept; parenteral
1.9
6.1
75
387
A49.0
ICD-10 Finland
Staphylococcal infection, unspecified site
3.7
6.1
24
65
DHB20
NOMESCO Finland
Polypectomy of internal nose
1.9
6.1
77
401
FM1LE
NOMESCO Finland
Combined ultrasound and EKG examination of heart with tolerance test
3.0
6.0
32
108
R28
ICPC
Limited function/disability (R)
2.2
6.0
58
268
J02AC04
ATC
posaconazole; systemic
8.6
6.0
12
14
4AA24
NOMESCO Finland
NA
8.6
6.0
12
14
RS321
NOMESCO Finland
NA
8.6
6.0
12
14
E83.58
ICD-10 Finland
Idiopathic hypercalciuria
4.9
6.0
18
37
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
2.6
6.0
41
161
RK230
NOMESCO Finland
NA
10.0
6.0
11
11
I15.8
ICD-10 Finland
Other secondary hypertension
4.4
6.0
20
46
L01AA02
ATC
chlorambucil; oral
4.4
6.0
20
46
SPAT1211
SPAT
Application of soft bandage
1.3
6.0
431
3349
Y0499
ICD-8 Finland
Investigation of respiratory system
2.2
6.0
55
248
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
1.6
6.0
138
861
R07.0
ICD-10 Finland
Pain in throat
1.4
6.0
287
2092
4239
FHL
Other measure in this category
3.0
6.0
31
103

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3010838) Calcium [Moles/time] in 24 hour Urine
334
306
11.33
315.06
1.5
1.7
mmol/24h
5.3
6.8
0.71
19
23
(3020779) Urea [Moles/volume] in Serum or Plasma
1639
5947
3.19
307.65
15.6
7.6
mmol/l
11.2
9.4
19.10
1587
5689
(3006504) Eosinophils/100 leukocytes in Blood
5470
32210
3.04
307.65
12.2
6.1
%
3.1
2.9
8.67
5314
30074
(3024139) IgG subclass 3 [Mass/volume] in Serum
567
679
8.89
307.65
1.9
1.3
g/l
0.3
0.4
6.69
425
472
(3027135) IgG subclass 1 [Mass/volume] in Serum
567
679
8.89
307.65
1.9
1.3
g/l
5.6
6.8
8.24
424
472
(3024561) Albumin [Mass/volume] in Serum or Plasma
4685
28956
2.42
307.65
8.6
4.9
g/l
35.4
35.7
3.57
4461
26944
(42870588) Differential panel, method unspecified - Blood
4583
23318
3.15
307.65
11.1
6.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
5380
30118
3.23
307.65
12.5
6.0
mmol/l
1.2
1.2
9.37
5130
27368
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
577
469
13.15
307.65
2.9
2.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
5924
35334
3.35
307.65
11.8
6.0
e9/l
1.8
1.9
8.75
5497
31107
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
725
1383
5.65
307.65
8.1
5.7
iu/ml
1822.4
1798.6
0.01
144
188
(3018010) Neutrophils/100 leukocytes in Blood
5472
32765
2.96
307.65
11.7
6.0
%
58.1
56.9
13.03
5320
30712
(3028026) IgM [Mass/volume] in Serum or Plasma
1543
4047
4.45
307.65
3.0
1.8
g/l
1.1
1.3
3.57
1420
3708
(4062490)
577
676
9.10
307.65
1.9
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
877
2104
4.54
307.65
1.9
1.6
g/l
1.2
1.2
0.30
830
1999
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
861
2034
4.61
307.65
1.9
1.7
g/l
0.2
0.2
0.19
804
1932
(1175426) CD3 cells/100 lymphocytes in Blood
580
507
12.22
307.65
2.9
2.0
%
72.5
72.6
0.02
560
485
(3000060) B lymphocytes [#/volume] in Blood
299
184
16.82
307.65
3.1
2.1
e6/l
435.7
306.7
0.32
202
95
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
499
429
12.31
307.65
3.0
2.6
e9/l
0.2
0.2
0.23
432
363
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
676
1313
5.52
307.65
1.6
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
340
250
14.14
307.65
1.7
1.7
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
568
679
8.91
307.65
1.9
1.3
g/l
2.4
2.9
6.48
423
473
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1440
4906
3.34
307.65
7.2
3.8
ng/l
111.1
87.6
9.62
1323
4255
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
742
260
31.24
307.65
4.5
1.6
u/ml
730.3
1497.5
2.02
737
260
(3013115) Eosinophils [#/volume] in Blood
5966
35649
3.39
307.65
12.1
6.2
e9/l
0.2
0.2
0.82
5537
31304
(3006245) CD3-CD19+ cells/100 cells in Blood
369
257
14.98
307.65
3.1
2.2
%
12.1
10.8
0.68
344
240
(21494815) CD4 cells/100 lymphocytes in Specimen
514
561
9.70
307.65
2.8
2.3
%
36.7
41.5
0.95
49
64
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
2516
1513
23.41
307.65
4.8
1.2
mg/l
11.1
11.1
0.02
2441
1390
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
609
1040
6.24
307.65
4.5
3.0
u/ml
3401.1
2146.5
0.26
35
59
(3003458) Phosphate [Moles/volume] in Serum or Plasma
2135
8746
2.94
307.65
13.9
5.9
mmol/l
1.1
1.0
9.10
2061
8156
(3002030) Lymphocytes/100 leukocytes in Blood
5520
33257
2.96
307.65
12.3
6.2
%
26.7
28.3
24.51
5365
31040
(3013650) Neutrophils [#/volume] in Blood by Automated count
6170
39663
3.16
307.65
15.0
9.3
e9/l
4.0
4.1
0.77
5725
34617
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
576
495
12.43
307.65
2.8
2.0
%
12.9
13.9
0.68
351
231
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
368
248
15.48
307.65
3.1
1.9
%
29.5
28.0
0.73
352
236
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1007
2061
5.42
307.65
2.6
2.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
3983
19510
3.00
307.65
8.8
4.0
ph
7.4
7.4
0.63
827
3779
(3009445) Proteinase 3 Ab [Units/volume] in Serum
1094
2852
4.27
307.65
1.6
1.6
u/ml
24.1
9.6
1.35
34
77
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
509
446
12.09
307.65
3.0
2.5
e6/l
534.7
513.6
0.26
432
367
(3022096) Basophils/100 leukocytes in Blood
5397
31250
3.07
307.65
12.1
6.2
%
0.7
0.7
4.79
5254
29208
(3006315) Basophils [#/volume] in Blood
5890
34503
3.43
307.65
11.6
5.9
e9/l
0.0
0.0
0.55
5427
29781
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
3149
2512
19.57
307.65
5.3
1.2
u/l
44.6
38.4
27.83
2992
2193
(3005719) IgG [Mass/volume] in Serum or Plasma
1920
5194
4.51
307.65
6.7
2.4
g/l
9.7
10.5
12.95
1826
4734
(3011412) CD3 cells [#/volume] in Blood
677
628
11.65
307.65
2.9
2.4
e9/l
1.3
1.2
1.41
482
373
(3019069) Monocytes/100 leukocytes in Blood
5483
32383
3.04
307.65
12.5
6.4
%
9.1
8.6
30.80
5331
30408
(3001604) Monocytes [#/volume] in Blood
5877
34360
3.43
307.65
11.6
5.9
e9/l
0.6
0.6
0.55
5411
29660
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
5828
33187
3.53
307.65
14.6
6.7
mmol/l
1.2
1.2
7.82
5029
28046
(3024980) IgG subclass 4 [Mass/volume] in Serum
679
1115
6.54
307.65
2.0
1.5
g/l
0.6
0.8
3.81
509
851
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
394
471
8.73
305.69
2.7
2.7
e6/l
606.7
693.0
0.93
131
185
(3005322) IgE [Units/volume] in Serum or Plasma
1285
4298
3.35
304.24
1.7
1.3
u/ml
211.9
216.3
0.04
1138
3985
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6952
52534
2.98
302.92
13.1
7.5
u/l
79.4
78.5
1.06
6763
49600
(3013707) Erythrocyte sedimentation rate by Westergren method
6768
50712
2.80
294.38
7.7
4.0
mm/h
13.9
11.7
24.79
6523
47148
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1786
7368
2.81
291.54
5.6
4.3
u/l
239.4
240.7
0.14
1715
6989
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
170
38
45.65
288.78
1.8
1.3
mg/l
1.0
1.6
0.38
110
22
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
4448
27914
2.28
286.49
3.3
2.3
nmol/l
75.4
76.9
3.45
4189
25258
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
167
37
46.04
284.23
1.8
1.3
mg/l
3.1
4.7
0.54
107
21
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
167
37
46.04
284.23
1.8
1.3
mg/l
2.4
3.3
0.39
108
21
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
167
37
46.04
284.23
1.8
1.3
mg/l
0.7
1.3
0.78
110
23
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
167
37
46.04
284.23
1.8
1.3
mg/l
1.5
2.4
0.49
118
26
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
167
37
46.04
284.23
1.8
1.3
mg/l
1.2
1.2
0.00
105
24
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
167
37
46.04
284.23
1.8
1.3
mg/l
1.5
2.2
0.38
98
21
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
167
37
46.04
284.23
1.8
1.3
mg/l
1.8
2.3
0.24
123
26
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
167
37
46.04
284.23
1.8
1.3
mg/l
2.2
3.3
0.49
115
25
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
167
37
46.04
284.23
1.8
1.3
mg/l
1.8
2.5
0.27
106
26
(3037522) Nuclear Ab [Titer] in Serum
2083
9473
2.60
278.81
1.5
1.3
titre
509.5
540.6
0.31
434
1934
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
5216
35251
2.29
276.71
8.4
6.3
umol/l
11.1
11.5
1.62
5033
33452
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1986
8891
2.62
274.01
4.8
2.5
%
22.8
23.0
0.24
1783
7619
(3004789) Transferrin [Mass/volume] in Serum or Plasma
2084
9569
2.57
272.68
4.6
2.5
g/l
2.3
2.3
6.21
1994
8895
(3022948) Iron [Moles/volume] in Serum or Plasma
2187
10347
2.51
267.97
4.5
2.5
umol/l
12.8
13.3
2.93
2100
9625
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
831
2283
3.93
263.39
1.7
1.6
titre
163.5
331.0
1.32
31
91
(3036603) Volume of Urine
340
415
8.50
259.09
2.1
1.6
ml
1799.0
1931.6
0.57
72
94
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
162
46
35.90
259.06
1.4
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
358
483
7.70
250.69
1.7
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1541
6328
2.76
250.37
2.6
2.2
nmol/l
338.8
369.1
8.27
1456
5831
(3026250) Tacrolimus [Mass/volume] in Blood
284
296
9.90
244.42
35.4
37.2
ug/l
7.0
7.5
2.23
262
271
(3010503) CD19 cells [#/volume] in Blood
317
390
8.41
239.89
2.6
2.7
e9/l
0.5
0.3
0.37
310
376
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
3127
18012
2.18
236.28
5.0
2.9
ng/l
1589.4
1315.0
2.12
2741
15367
(3015377) Calcium [Moles/volume] in Serum or Plasma
3656
22395
2.13
235.32
4.3
3.4
mmol/l
2.3
2.4
3.72
3339
19618
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
143
38
38.27
232.70
1.5
1.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
4134
26765
2.08
226.93
11.3
8.6
inr
1.2
1.2
0.86
1239
7759
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
197
132
15.26
224.04
1.4
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
4519
30386
2.07
221.97
17.3
9.5
e9/l
0.0
0.0
1.63
3877
24782
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
690
1901
3.87
216.67
8.1
4.5
mg/l
1.7
1.5
10.76
655
1768
(3007164) IgA [Mass/volume] in Serum or Plasma
2467
13343
2.21
214.45
2.5
1.4
g/l
2.2
2.4
6.10
1748
8168
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
543
1277
4.48
211.00
2.0
1.5
u/ml
105.6
117.1
1.27
121
264
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
662
1810
3.89
209.99
1.6
1.4
iu/ml
13.4
15.0
0.09
20
40
(3023368) Bacteria identified in Blood by Culture
3003
17673
2.09
208.63
6.6
4.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
1300
5357
2.69
206.80
2.9
2.5
g/l
65.6
66.6
4.32
1237
4895
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
571
1418
4.25
206.64
2.0
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
569
1415
4.24
205.52
1.9
1.4
u/ml
23.8
19.5
0.23
11
29
(3017181) Myelocytes/100 leukocytes in Blood
1352
5725
2.63
203.38
6.1
4.2
%
0.8
0.9
0.73
459
1593
(3000850) Epithelial cells [#/volume] in Urine
2520
13990
2.15
203.09
4.3
2.5
e6/l
4.5
5.4
2.16
2304
12254
(3002179) Metamyelocytes/100 leukocytes in Blood
1264
5221
2.68
199.66
5.7
4.0
%
0.5
0.6
0.31
358
1143
(3042631) Mycobacterium sp identified in Specimen
418
830
5.25
198.90
2.8
2.7
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
291
415
7.23
193.68
2.0
1.4
u/l
13.2
12.2
1.13
286
400
(3042733) HLA Ab [Presence] in Serum
219
221
10.15
192.76
5.8
4.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
3257
20188
2.01
192.37
5.4
3.2
e6/l
56.3
85.9
1.28
2710
15419
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
579
1535
3.98
191.45
2.3
1.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1998
10332
2.23
190.84
3.1
2.2
s
29.7
29.8
0.50
1945
10034
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
586
1576
3.92
189.88
2.2
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
1872
9519
2.25
185.69
2.6
2.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
2980
18073
2.01
185.67
5.0
3.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
3629
23561
1.96
185.57
6.3
3.6
e6/l
73.9
92.0
0.61
2864
16657
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
391
783
5.19
184.13
1.1
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
1267
5446
2.57
183.47
6.2
4.2
%
0.1
0.2
1.24
432
1475
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
546
1431
4.01
183.30
1.5
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
525
1339
4.12
182.95
1.5
1.3
u/ml
251.3
267.3
0.60
372
815
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
205
204
10.28
182.21
2.3
2.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
3016
18547
1.98
179.11
5.2
3.1
e6/l
0.3
0.4
1.60
2446
13899
(40758558) Short blood count panel - Blood
2891
17525
2.00
178.88
11.0
7.0
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
249
326
7.84
178.62
28.1
26.8
ug/l
104.1
119.1
2.65
209
268
(3025159) Blasts/100 leukocytes in Blood
1207
5141
2.58
177.76
6.3
4.2
%
0.3
0.2
0.09
381
1238
(40760892) CBC W Ordered Manual Differential panel - Blood
2605
15304
2.02
175.49
8.3
4.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
382
782
5.07
175.32
3.7
2.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
5322
39725
1.94
174.45
8.2
4.7
mmol/l
6.7
6.7
0.65
5091
37160
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1969
10460
2.16
173.60
2.5
1.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
1072
4365
2.67
172.75
2.6
2.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2038
11022
2.12
171.21
6.0
3.5
mmol/l
0.8
0.8
0.91
1941
10316
(46235355) HIV 1 and 2 tests - Meaningful Use set
2076
11335
2.11
169.90
2.2
1.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
2920
18047
1.95
168.53
4.3
2.6
umol/l
2334.2
4153.4
2.43
2625
15730
(21494814) CD8 cells/100 lymphocytes in Specimen
215
257
8.56
166.29
2.3
2.1
—
—
—
0
0
(3026782) Osmolality of Urine
2274
12942
2.04
165.71
4.6
2.7
mosm/kgh2o
525.0
549.1
7.01
2052
11036
(3037467) Urinalysis macro (dipstick) panel - Urine
5934
46343
1.98
165.25
6.9
4.2
—
—
—
0
0
(3012565) Volume of 24 hour Urine
234
325
7.38
159.36
2.1
2.3
ml
1940.5
2003.5
0.32
220
288
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
658
2140
3.25
158.96
1.7
1.6
iu/ml
0.4
4.9
0.88
151
461
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
432
1057
4.26
158.84
1.4
1.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
144
102
14.35
158.68
5.5
6.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
644
2089
3.26
156.18
1.5
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
3054
19581
1.88
154.49
5.3
3.2
mg/l
741.6
413.8
2.46
2220
12443
(3009508) Creatinine [Moles/volume] in Urine
3230
21111
1.87
153.58
5.2
3.2
mmol/l
7.3
7.7
7.12
2863
17876
(3027945) Reticulocytes/100 erythrocytes in Blood
1456
7191
2.24
151.90
4.6
2.6
%
1.9
1.8
3.17
1334
6409
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
440
1131
4.05
151.30
2.2
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
273
472
5.95
150.62
1.9
1.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
471
1282
3.83
149.45
1.3
1.2
titre
482.5
95.2
—
8
25
(3020682) Albumin/Creatinine [Ratio] in Urine
3148
20557
1.86
148.91
6.4
3.9
mg/mmol
21.7
9.9
12.77
2281
13101
(3001122) Ferritin [Mass/volume] in Serum or Plasma
4098
29012
1.81
148.65
4.9
2.8
ug/l
170.2
128.6
5.74
3898
26968
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1443
7161
2.23
148.50
2.2
1.7
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
247
393
6.45
148.13
2.7
2.6
%
41.5
40.5
0.23
114
128
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
327
680
4.96
147.15
1.2
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
438
1146
3.98
146.92
1.8
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
335
712
4.86
146.91
2.3
2.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1440
7193
2.21
145.56
2.3
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
1521
7775
2.17
145.04
2.2
1.6
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
211
296
7.29
142.37
2.0
2.0
umol/l
2.0
1.9
0.10
198
277
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
375
896
4.34
142.08
2.0
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
3633
25107
1.79
140.16
5.3
3.4
ng/l
35.6
66.3
0.93
2658
16559
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1055
4739
2.40
136.36
2.2
1.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
746
2840
2.79
135.70
2.2
1.7
g/l
1.4
1.5
2.22
641
2449
(3023520) Reticulocytes [#/volume] in Blood
1148
5368
2.32
135.30
4.0
2.6
e9/l
74.1
69.8
2.69
872
4033
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3349
22896
1.77
131.60
4.5
3.3
u/l
32.0
35.0
1.69
3200
21713
(3012544) pH of Venous blood
1297
6457
2.20
131.07
10.2
4.0
ph
7.4
7.4
—
8
39
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1707
9463
2.01
129.45
2.2
1.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
576
1960
3.08
128.29
3.8
3.2
mg/l
65.1
81.4
0.22
448
1587
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
565
1902
3.11
128.19
3.8
3.2
ratio
2.9
2.7
0.06
44
156
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
575
1959
3.08
127.78
3.8
3.2
mg/l
43.4
50.9
0.39
446
1588
(3002032) Base excess in Venous blood by calculation
1252
6206
2.20
127.65
10.3
4.1
mmol/l
1.3
1.9
7.65
1047
5041
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1253
6220
2.19
127.25
10.3
4.1
kpa
5.8
5.8
0.80
1217
6039
(3031040) Bacteria [#/volume] in Urine by Automated count
5520
43796
1.78
125.68
6.0
4.3
e6/l
898.5
1288.8
0.37
80
566
(3033658) Prothrombin time (PT) actual/Normal
2713
17620
1.80
125.54
6.1
4.0
%
93.1
90.8
4.77
2656
17179
(3009261) Glucose [Presence] in Urine by Test strip
4458
33334
1.73
125.22
5.3
3.5
estimate
0.0
0.0
0.36
986
5938
(3035350) Ketones [Presence] in Urine by Test strip
4410
32885
1.73
125.04
5.3
3.5
estimate
0.0
0.0
1.08
996
5970
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
239
438
5.59
123.91
1.4
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
1493
8023
2.05
122.79
2.4
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
4408
32986
1.72
122.28
7.1
4.7
estimate
0.0
0.0
0.29
1017
6118
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
349
901
4.00
119.02
1.8
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
1155
5690
2.20
119.00
15.2
8.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
307
732
4.32
116.47
2.1
1.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
167
226
7.52
116.29
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
168
230
7.43
115.80
1.0
1.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2536
16456
1.78
115.73
2.9
2.3
mg/l
3.2
2.9
4.99
2293
14127
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1103
5404
2.20
114.96
4.5
2.8
ng/l
190.5
181.6
0.27
1000
4894
(3000494) Fungus identified in Specimen by Culture
1471
8061
2.00
113.70
2.0
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
455
1457
3.25
112.03
2.4
2.2
g/l
131.2
129.6
0.48
246
1049
(40760888) Immunoglobulin light chains.free panel - Serum
457
1471
3.23
111.56
3.8
3.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
574
2109
2.85
111.05
2.0
1.8
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
678
2723
2.62
110.30
1.3
1.2
u/ml
1.0
1.1
0.07
60
257
(4010399)
1007
4847
2.23
109.33
1.7
1.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
255
555
4.71
108.50
2.3
1.9
g/24h
0.9
1.3
0.50
29
35
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
326
869
3.86
106.22
1.8
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
1025
5042
2.18
105.20
1.7
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
921
4360
2.25
103.85
6.0
3.9
kpa
5.1
5.1
2.38
872
4039
(3009343) pH of Capillary blood
911
4304
2.25
103.19
5.9
3.9
ph
7.4
7.4
0.70
153
506
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
350
1000
3.61
103.02
1.8
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1217
6451
2.04
102.34
3.1
2.3
g/l
0.2
0.2
4.66
1152
6024
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
197
362
5.55
101.80
1.3
1.0
u/l
1.2
1.1
1.03
103
172
(44790049)
295
755
4.01
101.72
2.2
1.5
—
—
—
0
0
(44790047)
295
755
4.01
101.72
2.2
1.5
—
—
—
0
0
(44790048)
295
755
4.01
101.72
2.2
1.5
—
—
—
0
0
(44806118)
295
755
4.01
101.72
2.2
1.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
767
3393
2.39
101.21
12.6
4.5
mmol/l
23.6
24.1
5.59
708
3073
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
882
4153
2.26
100.60
5.9
3.9
mmol/l
1.5
1.7
0.87
674
3068
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
2054
12966
1.78
100.52
5.8
3.6
ng/l
364.1
502.1
0.69
1579
9850
(3029634) Reagin Ab [Titer] in Serum by VDRL
335
948
3.64
100.01
2.1
2.2
titre
0.3
7.3
—
6
28
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
7666
69206
2.39
99.84
28.1
13.6
mg/l
19.8
23.4
22.57
6825
54508
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1063
5437
2.10
98.20
7.0
3.9
mmol/l
1.2
1.2
0.04
994
4770
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
3022
21314
1.66
97.75
3.3
2.6
u/l
58.3
57.9
0.12
2856
19724
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
97
80
12.26
97.59
12.6
11.4
mmol/l
5.3
5.8
0.62
97
80
(3014148) Varicella zoster virus Ab [Titer] in Serum
304
831
3.76
95.48
1.2
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
282
740
3.91
93.89
2.7
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
316
900
3.61
93.40
1.2
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1832
11404
1.78
93.02
3.9
2.7
e6/l
1.0
1.1
0.55
1115
6450
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
616
2565
2.51
92.54
2.6
1.9
ug/l
2.0
2.2
0.13
566
2279
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
152
239
6.46
92.15
1.1
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
245
590
4.25
91.67
4.2
3.7
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
94
82
11.58
91.25
6.9
5.1
ug/min
34.4
47.3
0.82
74
62
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
148
229
6.56
91.13
1.1
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
599
2479
2.53
91.12
2.7
2.2
g/l
3.8
3.8
0.08
446
1778
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
599
2481
2.52
90.96
2.7
2.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
599
2483
2.52
90.80
2.7
2.2
g/l
7.2
7.4
1.34
457
1866
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2888
20427
1.63
90.62
2.6
2.2
u/l
185.3
211.4
0.43
2730
19218
(40768795) Lymph node Pathology biopsy report
256
645
4.06
90.16
1.3
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
2275
15170
1.69
89.66
2.6
1.8
mg/l
1.3
1.2
0.67
1808
11585
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
135
194
7.06
89.08
2.7
3.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
261
674
3.97
88.85
2.8
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
385
1285
3.09
88.17
1.6
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
144
226
6.47
87.46
1.5
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
567
2333
2.54
87.23
2.8
2.2
g/l
3.0
3.1
0.72
450
1827
(3024354) Oxygen [Partial pressure] in Venous blood
988
5133
2.05
86.88
8.7
3.5
kpa
5.2
4.7
6.25
957
4967
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
372
1230
3.12
86.56
5.9
3.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
560
2312
2.52
85.50
2.8
2.2
g/l
9.7
10.2
1.51
478
1952
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
539
2193
2.56
84.84
4.8
3.6
u/ml
0.3
0.3
0.00
301
1242
(3014576) Chloride [Moles/volume] in Serum or Plasma
1399
8300
1.82
82.32
11.3
7.2
mmol/l
104.1
104.5
2.52
1367
8134
(3019550) Sodium [Moles/volume] in Serum or Plasma
7719
70761
2.27
81.98
30.3
15.5
mmol/l
139.6
139.7
1.34
7633
69074
(3018133) Calcium [Moles/volume] in Urine
106
127
8.44
81.76
2.5
2.0
mmol/l
2.9
2.3
1.11
100
110
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1685
10599
1.74
81.04
4.3
2.9
e6/l
2.4
2.4
0.07
967
5680
(3044640) Blood type and Crossmatch panel - Blood
2937
21308
1.59
80.49
3.4
2.4
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
94
99
9.59
80.08
3.6
2.8
mg/l
14.6
41.0
—
7
22
(3023103) Potassium [Moles/volume] in Serum or Plasma
7728
70991
2.26
79.71
30.9
15.6
mmol/l
4.0
4.0
1.08
7638
69166
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
498
2009
2.57
79.70
5.2
2.9
g/l
3.6
3.6
0.07
475
1908
(3037121) Protein [Mass/volume] in Urine
539
2277
2.46
78.20
4.6
3.3
g/l
0.5
0.3
1.48
329
999
(3000492) Spirometry study
1183
6769
1.87
77.81
2.1
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
5689
48064
1.58
77.64
4.9
3.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1835
11936
1.69
77.61
1.4
1.3
iu/ml
35.2
33.3
0.17
602
3732
(4035726)
1080
6028
1.91
76.63
1.6
1.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
466
1858
2.60
76.35
2.9
2.1
g/l
0.0
0.0
0.14
429
1709
(3003396) Base excess in Arterial blood by calculation
1281
7562
1.82
76.08
10.5
7.4
mmol/l
1.0
1.0
0.32
1018
5910
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
846
4358
2.05
75.62
12.9
7.6
mmol/l
24.4
24.8
3.69
839
4332
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
468
1881
2.58
75.41
1.6
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
134
229
5.93
74.76
1.7
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
503
2103
2.48
74.57
3.0
2.2
g/l
0.8
0.8
0.14
448
1818
(1616796) Gas panel - Central venous blood
395
1470
2.77
74.14
5.1
3.7
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
136
239
5.77
73.71
1.8
1.8
u/ml
59614.6
16010.5
0.32
16
32
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
477
1957
2.52
73.60
2.0
1.7
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1274
7581
1.80
73.47
10.7
7.3
kpa
5.0
5.1
1.21
1202
7242
(3027801) Oxygen [Partial pressure] in Arterial blood
1273
7580
1.80
73.23
10.7
7.3
kpa
11.8
12.6
4.94
1203
7241
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1170
6791
1.84
73.20
4.1
3.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
234
642
3.72
73.05
2.2
2.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
996
5500
1.92
72.76
3.4
2.6
ml/min/173m2
55.8
68.2
17.49
462
2137
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1318
7951
1.78
72.49
3.7
2.9
umol/l
6.8
8.2
2.47
1166
6918
(3015235) Bicarbonate [Moles/volume] in Capillary blood
423
1651
2.65
72.31
3.8
3.2
mmol/l
24.1
24.8
2.75
384
1436
(3016502) Oxygen saturation in Arterial blood
1153
6749
1.82
69.95
11.3
7.8
%
95.6
95.7
0.34
1093
6498
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
380
1434
2.73
69.40
2.5
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
380
1437
2.72
69.11
1.2
1.2
u/ml
13.4
23.0
—
8
18
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
3986
31627
1.50
68.95
5.4
4.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
2218
15527
1.58
68.44
5.1
3.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1788
11882
1.64
68.42
3.1
3.1
mmol/l
2.5
2.5
0.56
1598
10400
(3014111) Lactate [Moles/volume] in Serum or Plasma
1033
5884
1.86
68.31
12.7
7.2
mmol/l
1.3
1.3
0.09
993
5668
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2301
16266
1.57
67.98
3.3
2.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
423
1707
2.56
67.49
2.8
2.1
g/l
0.0
0.0
0.00
390
1582
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
426
1729
2.54
67.16
2.8
2.1
g/l
0.0
0.0
0.61
390
1584
(3004119) Hemoglobin [Mass/volume] in Venous blood
764
3964
2.02
66.59
8.4
3.4
g/l
123.0
130.1
13.09
745
3863
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
375
1439
2.68
66.25
1.2
1.2
u/ml
3.5
4.0
0.10
46
104
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1073
6246
1.82
66.02
11.7
8.1
g/l
120.1
122.1
2.16
1023
6015
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1702
11283
1.64
65.36
1.3
1.3
u/ml
9.2
11.5
0.76
611
4485
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
454
1928
2.43
64.92
2.8
2.1
g/l
38.0
37.9
0.13
415
1665
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
455
1937
2.43
64.71
1.3
1.3
u/ml
21.7
43.3
1.46
36
120
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
205
570
3.66
62.76
1.3
1.2
titre
200.0
167.2
0.20
34
109
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
205
570
3.66
62.76
1.3
1.2
titre
273.6
85.3
0.61
11
17
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
61
49
12.53
62.31
1.7
1.9
ug/g
191.7
129.7
1.69
50
44
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
131
260
5.10
62.17
2.8
2.7
—
—
—
0
0
(3019225) pH of Specimen
1093
6509
1.78
62.06
8.2
4.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
410
1699
2.49
61.80
5.3
4.1
kpa
8.9
8.5
4.41
391
1574
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
106
175
6.12
61.28
1.3
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
89
125
7.19
59.99
2.3
2.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
456
2013
2.34
59.70
4.8
2.7
%
199.2
188.8
1.50
429
1918
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
399
1659
2.48
59.69
1.2
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
3537
27924
1.46
59.57
2.3
2.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
600
2967
2.10
59.38
8.2
3.0
%
0.7
0.7
0.23
587
2838
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
468
2100
2.30
58.98
1.7
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
710
3748
1.98
58.66
1.7
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
630
3188
2.06
58.59
6.7
4.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
6467
57549
1.56
58.59
31.8
16.7
%
13.8
13.7
17.78
6398
56340
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
414
1768
2.41
58.41
1.3
1.3
u/ml
2.5
5.1
0.77
52
174
(3052851) Hemolysis interference index of Serum or Plasma
456
2033
2.32
58.33
3.5
3.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
313
1172
2.74
57.97
3.6
2.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
3272
25554
1.46
57.71
5.6
3.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
299
1097
2.79
57.58
3.8
3.5
%
1.0
1.6
2.57
257
843
(3019309) Folate [Moles/volume] in Red Blood Cells
1728
11811
1.58
57.50
1.9
1.7
nmol/l
1224.6
1167.2
1.63
1391
9031
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
416
1794
2.39
57.41
1.3
1.3
u/ml
5.7
7.3
0.24
76
282
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
183
502
3.70
57.17
1.9
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
2558
19059
1.49
57.15
3.7
3.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
71
81
8.83
56.93
1.9
1.9
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
292
1066
2.80
56.76
1.9
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
230
736
3.19
56.49
1.7
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
445
1995
2.30
56.16
1.3
1.3
titre
77.2
140.3
1.12
46
171
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
481
2235
2.22
55.70
4.5
2.7
%
96.1
91.8
3.65
455
2092
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
848
4840
1.84
55.07
2.4
2.4
au/ml
16.3
23.4
0.63
25
285
(3019060) Gas panel - Arterial blood
778
4326
1.88
54.88
6.4
4.8
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
261
916
2.91
54.58
9.0
6.7
mg/l
11.7
11.4
0.64
236
853
(3029937) Albumin [Presence] in Urine by Test strip
2377
17593
1.49
54.28
6.1
3.9
estimate
0.0
0.0
0.63
957
5890
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
188
544
3.51
54.23
1.3
1.1
mg/l
40.1
41.0
0.11
159
452
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
177
498
3.61
53.27
1.2
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
1312
8537
1.64
53.06
2.5
2.4
ug/g
150.4
129.0
1.03
1078
6772
(3034770) Mitochondria Ab [Titer] in Serum
436
1985
2.26
53.02
1.3
1.2
titre
526.7
994.4
1.10
12
59
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
3388
26938
1.44
52.84
2.2
1.9
pmol/l
96.5
96.1
0.18
1864
14091
(3017704) Immunofixation for Urine
138
330
4.24
52.17
1.4
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
514
2515
2.11
52.16
6.9
1.5
mg/l
4.0
3.8
0.15
451
1763
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
97
173
5.66
51.82
1.7
2.0
u/l
16.4
49.1
1.47
87
160
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
180
523
3.50
51.61
1.2
1.1
mg/l
292.9
270.5
0.45
161
457
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
779
4422
1.84
51.33
1.3
1.3
au/ml
55.7
51.1
0.15
22
200
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
153
400
3.88
51.24
1.9
1.5
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
174
497
3.55
51.21
2.0
1.9
mg/l
4.7
4.1
0.79
168
475
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
161
438
3.73
50.93
2.3
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
581
3010
2.00
50.43
1.3
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
282
1076
2.68
50.33
1.3
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
131
310
4.28
50.21
1.4
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
187
567
3.35
50.16
2.1
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
187
567
3.35
50.16
2.1
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
187
567
3.35
50.16
2.1
1.7
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
585
3056
1.98
49.57
5.8
3.4
mmol/l
24.9
25.3
1.95
560
2960
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
160
442
3.67
49.50
2.3
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
2049
14948
1.49
49.38
1.8
1.5
nmol/l
20.0
20.4
0.49
1811
12862
(3036489) Thrombin time
523
2629
2.06
49.34
4.1
2.3
s
22.2
21.5
1.45
465
2289
(3008152) Bicarbonate [Moles/volume] in Arterial blood
731
4118
1.85
49.29
9.1
7.0
mmol/l
24.6
24.6
0.11
673
3834
(3041096) Erythrocytes [Presence] in Urine by Automated
2385
17958
1.46
48.84
4.8
3.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
5951
52745
1.45
48.48
4.7
4.0
pmol/l
14.9
14.7
4.59
5554
48299
(40767503) Oxygen content in Capillary blood by calculation
335
1416
2.42
48.29
3.4
2.5
%
16.9
16.4
1.77
208
709
(3051651) Icteric interference index of Serum or Plasma
149
400
3.77
48.07
4.0
3.7
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
354
1537
2.36
48.05
2.3
1.3
mmol/l
3.7
3.8
0.23
325
1441
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
386
1745
2.27
47.69
2.3
1.4
mg/l
579.2
513.9
0.44
367
1662
(3012501) Base excess in Blood by calculation
351
1525
2.36
47.57
5.4
4.2
mmol/l
2.1
2.5
2.00
252
1044
(3013290) Carbon dioxide [Partial pressure] in Blood
351
1526
2.36
47.50
5.4
4.2
kpa
4.9
5.0
2.42
345
1500
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
137
352
3.94
47.03
2.0
1.5
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
351
1536
2.34
46.79
5.4
4.2
kpa
8.8
8.6
1.06
345
1509
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
657
3639
1.87
46.65
15.3
10.0
—
—
—
0
0
(3010421) pH of Blood
389
1785
2.24
46.36
5.4
4.2
ph
7.4
7.4
0.23
347
1501
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
458
2245
2.10
46.18
3.1
2.3
ug/l
544.3
613.6
0.12
428
2113
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
311
1297
2.45
46.17
1.6
1.6
—
—
—
0
0
(4027681)
148
407
3.68
46.12
1.3
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
332
1427
2.38
46.10
2.5
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
136
355
3.88
45.68
2.0
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
460
2270
2.09
45.56
2.3
1.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
209
718
2.96
45.44
5.4
3.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
327
1406
2.38
45.37
1.5
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
334
1450
2.36
45.34
1.3
1.3
u/ml
31.9
42.3
0.76
56
143
(3016750) Collection duration of Urine
138
367
3.81
45.14
3.5
2.1
min
500.1
494.3
0.31
118
276
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
537
2818
1.97
44.82
7.3
4.2
mmol/l
24.6
24.8
0.50
499
2615
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
72
111
6.53
44.55
1.7
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
327
1418
2.36
44.50
12.1
3.6
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
345
1538
2.30
44.04
2.5
1.5
e6/l
45.0
22.7
0.27
269
1174
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
345
1538
2.30
44.04
2.5
1.5
e6/l
218.4
1223.4
3.83
280
1244
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
321
1390
2.36
43.83
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
321
1390
2.36
43.83
1.4
1.3
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
232
863
2.74
43.53
1.3
1.3
u/ml
49.1
57.5
0.19
23
55
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
160
482
3.37
43.40
1.7
1.3
u/ml
0.7
1.2
0.58
94
213
(40761535) Cells panel - Urine sediment
878
5413
1.70
43.13
5.9
3.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
7035
64937
1.54
42.69
23.0
12.6
ml/min/173m2
77.4
82.6
57.22
6315
53739
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
204
727
2.85
41.52
1.2
1.2
u/l
79.3
65.1
0.29
154
489
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
658
3778
1.81
41.47
1.9
1.7
—
—
—
0
0
(3025315) Body weight
50
56
8.98
40.67
5.5
4.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
6846
63000
1.49
40.41
5.6
4.7
mu/l
2.0
2.2
1.61
6443
58053
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1002
6500
1.62
40.18
2.8
2.5
u/l
37.9
44.5
0.41
872
5578
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
704
4165
1.75
40.01
12.9
9.3
%
0.7
0.7
0.12
696
4138
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
184
638
2.93
39.38
1.1
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
6861
63244
1.49
39.38
7.3
5.5
mmol/mol
40.5
39.6
11.97
6525
58853
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
116
302
3.88
39.15
5.1
3.9
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
703
4185
1.74
39.06
12.8
9.2
%
1.4
1.4
0.28
693
4164
(3023420) DNA double strand Ab [Units/volume] in Serum
202
745
2.75
38.56
1.2
1.5
iu/ml
28.7
29.1
—
9
34
(3004616) Nuclear Ab [Presence] in Serum
218
836
2.65
38.56
1.2
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
195
706
2.80
38.55
1.5
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
1145
7758
1.55
37.94
1.4
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
1346
9456
1.51
37.66
1.3
1.2
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
98
236
4.19
36.80
1.8
1.1
g/l
0.9
0.1
1.09
13
12
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
117
322
3.67
36.49
1.1
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
699
4259
1.70
35.60
3.6
3.3
pmol/l
4.4
4.5
1.82
627
3799
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
119
337
3.57
35.58
2.4
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
119
337
3.57
35.58
2.4
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
119
337
3.57
35.58
2.4
2.0
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
153
507
3.06
35.51
3.4
2.2
ml
748.7
632.4
2.67
128
344
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
135
418
3.27
35.11
1.3
1.2
u/l
102.6
89.3
0.49
126
358
(40761536) Microorganisms panel - Urine sediment
872
5642
1.61
35.08
6.9
3.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
316
1492
2.16
35.06
2.0
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
118
337
3.54
34.84
2.4
2.0
—
—
—
0
0
(3013512) EKG study
2419
19143
1.37
34.69
4.6
3.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
647
3887
1.72
34.67
1.4
1.2
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
93
226
4.15
34.52
1.9
1.2
%
96.3
112.2
2.71
83
200
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
100
257
3.93
34.41
2.5
2.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
100
257
3.93
34.41
2.5
2.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
7752
73854
1.74
34.37
18.8
10.2
u/l
27.7
27.1
2.05
7630
71392
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
137
437
3.17
33.94
1.4
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
110
307
3.62
33.63
1.2
1.1
iu/ml
2.9
3.8
—
7
17
(3009871) Measles virus Ab [Titer] in Serum
95
241
3.98
33.29
1.8
1.7
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
593
3516
1.74
33.28
13.7
9.6
mmol/l
24.2
24.3
0.39
551
3294
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
99
259
3.86
33.24
2.5
2.2
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
129
403
3.24
33.09
1.3
1.2
u/l
21.9
23.0
0.11
118
336
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
364
1853
2.01
33.04
1.2
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
110
311
3.57
32.99
4.1
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
110
311
3.57
32.99
4.1
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1971
15189
1.39
32.95
1.3
1.3
u/ml
2.1
1.8
0.32
498
4110
(40765096) Chromosome analysis panel by Banding
84
197
4.30
32.68
1.3
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
378
1958
1.97
32.66
1.3
1.3
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
95
245
3.91
32.55
1.9
1.2
g/l
0.3
0.3
0.81
66
204
(3019832) Treponema pallidum Ab [Presence] in Serum
804
5197
1.61
32.36
1.7
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
207
847
2.48
32.07
2.3
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
251
1123
2.27
31.80
1.2
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
209
863
2.46
31.76
2.3
1.4
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
102
284
3.62
31.32
6.6
5.7
mg/l
4422.0
885.8
0.74
92
204
(3000570) Elastase.pancreatic [Mass/mass] in Stool
380
2002
1.94
31.25
1.5
1.4
ug/g
296.8
272.8
1.42
233
1157
(3051611) Lipemic interference index of Serum or Plasma
175
670
2.65
31.12
3.9
3.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
204
842
2.46
31.03
2.3
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
148
520
2.88
31.00
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
148
520
2.88
31.00
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
148
521
2.87
30.90
1.2
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
204
845
2.45
30.80
2.3
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
147
517
2.88
30.74
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
147
517
2.88
30.74
1.2
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
203
840
2.45
30.72
2.3
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
147
518
2.87
30.64
1.2
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1829
14092
1.38
30.19
1.7
1.7
pmol/l
13587756.7
30345374.2
1.31
1575
11857
(3024522) Salmonella sp identified in Specimen by Organism specific culture
203
849
2.43
30.02
2.3
1.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
238
1069
2.26
29.89
2.4
1.9
mmol/l
1.6
1.7
1.54
231
1041
(40761511) CBC panel - Blood by Automated count
7577
72083
1.58
29.86
23.5
12.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
80
195
4.13
29.62
2.1
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
155
573
2.74
29.54
1.3
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
253
1171
2.20
29.54
1.1
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
157
585
2.72
29.47
1.2
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
187
764
2.48
29.10
2.4
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
164
630
2.64
28.99
1.1
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
171
672
2.58
28.87
3.3
3.4
%
61.4
57.6
1.26
129
423
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
5244
47116
1.31
28.60
4.5
3.1
u/l
58.4
48.5
10.53
4954
44167
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
102
302
3.41
28.56
1.1
1.1
miu/ml
1464.0
1470.7
0.02
102
302
(3020891) Body temperature
460
2650
1.78
28.48
5.7
4.7
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
486
2846
1.75
28.44
5.4
4.0
%
51.4
49.1
1.16
479
2808
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
140
505
2.80
27.97
1.6
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
342
1808
1.93
27.84
1.6
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
189
807
2.37
26.73
2.8
2.2
pg
32.3
32.7
0.49
189
801
(3017732) Neutrophils [#/volume] in Blood
725
4796
1.56
26.23
2.9
2.9
e9/l
4.3
4.1
1.64
585
3796
(3030981) Hyaline casts [#/volume] in Urine by Automated count
550
3404
1.66
26.22
4.7
2.6
e6/l
0.2
0.3
1.98
538
3302
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
52
99
5.28
26.00
1.7
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
337
1819
1.89
25.77
1.3
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
123
433
2.87
25.75
1.1
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
174
729
2.42
25.68
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
227
1066
2.16
25.60
1.3
1.2
u/ml
4.1
4.3
0.07
96
456
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
140
530
2.67
25.53
1.2
1.2
u/ml
84.9
69.0
0.29
15
23
(3009214) Lutropin [Units/volume] in Serum or Plasma
359
1984
1.85
25.49
1.9
1.4
u/l
10.3
10.0
0.16
296
1600
(40757373) Influenza virus identified in Isolate
57
120
4.78
25.41
1.8
1.6
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
32
37
8.68
25.38
1.2
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
32
37
8.68
25.38
4.1
3.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
140
534
2.65
25.16
1.2
1.2
u/ml
36.2
36.9
0.01
15
42
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
211
971
2.20
25.04
1.1
1.1
g/l
1.5
1.5
0.21
200
876
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
39
58
6.75
25.01
5.1
5.2
mg/l
2.1
2.7
0.76
32
46
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
242
1177
2.09
24.93
1.1
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
378
2140
1.80
24.81
9.6
5.9
mmol/l
1.4
1.3
1.19
326
1873
(3047189) Immunofixation for 24 hour Urine
97
305
3.21
24.72
2.0
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
107
360
3.00
24.31
1.2
1.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
110
376
2.95
24.31
1.8
1.5
ug/l
10.3
7.8
0.35
100
335
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
228
1096
2.11
24.23
1.3
1.2
u/ml
2.8
3.9
0.71
71
347
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
134
510
2.65
24.20
1.2
1.2
u/ml
1.9
5.4
0.84
11
33
(3030313) Adrenal Ab [Titer] in Serum
34
45
7.58
24.17
1.7
1.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
36
51
7.09
24.13
6.5
3.2
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
140
546
2.59
24.08
1.2
1.2
u/ml
49.6
55.4
—
10
26
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
300
1595
1.91
24.03
3.6
2.3
ug/min
257.2
97.8
3.01
209
980
(3019150) Specific gravity of Urine by Refractometry
1811
14357
1.33
24.03
5.6
3.9
kg/l
1.0
1.0
0.20
247
2127
(3022217) INR in Platelet poor plasma by Coagulation assay
1144
8443
1.41
23.76
27.0
23.1
inr
1.4
1.3
0.31
168
1265
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
153
628
2.46
23.65
1.4
1.3
titre
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
448
2700
1.70
23.60
8.4
5.1
%
1.7
1.7
0.50
405
2518
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
809
5603
1.49
23.54
2.5
2.3
ug/l
9.1
7.5
0.69
721
4926
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
455
2758
1.69
23.46
1.2
1.1
u/ml
86.3
2.2
1.17
14
37
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
38
59
6.47
23.42
1.1
1.1
u/l
29.2
22.2
0.63
28
42
(3021788) Differential panel - Synovial fluid
243
1214
2.03
23.30
1.7
1.5
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
30
36
8.36
23.11
10.1
12.5
e6/l
135.8
140.8
0.03
24
28
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
28
31
9.06
22.94
5.0
3.9
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
28
31
9.06
22.94
5.0
3.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
4970
44927
1.26
22.88
3.4
3.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
441
2671
1.69
22.81
8.6
5.2
%
0.9
0.9
1.58
398
2496
(4015189)
65
166
3.94
22.68
2.3
2.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
394
2318
1.73
22.66
4.3
4.0
mmol/l
1.3
1.4
0.56
382
2285
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
117
430
2.75
22.65
1.7
1.5
u/l
5.2
6.4
1.45
97
370
(3016244) Insulin [Units/volume] in Serum or Plasma
117
436
2.71
22.06
3.8
3.3
mu/l
25.6
27.8
0.23
111
417
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
416
2504
1.70
22.02
2.7
1.8
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
79
237
3.36
21.76
2.1
3.1
au/ml
98.5
124.4
0.19
12
33
(3008898) HLA-B27 [Presence]
407
2445
1.70
21.70
1.1
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
128
504
2.56
21.63
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
295
1619
1.85
21.45
1.9
1.6
e6/l
12993.5
13340.5
0.05
225
1167
(3032352) Blasts [#/volume] in Cerebral spinal fluid
40
72
5.58
21.28
6.7
2.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
99
346
2.88
21.08
1.1
1.2
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
19
13
14.65
21.05
2.4
1.2
mg/l
41.0
93.1
0.57
19
13
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
57
140
4.09
20.99
1.5
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
441
2737
1.65
20.76
2.7
1.9
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
56
137
4.11
20.73
1.2
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
119
464
2.59
20.54
1.1
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
69
197
3.52
20.54
1.4
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1563
12378
1.32
20.45
1.6
1.5
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
119
466
2.58
20.36
1.1
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
339
1976
1.75
20.17
4.5
4.2
mmol/l
3.9
3.9
1.00
310
1867
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
80
254
3.17
20.14
2.6
3.8
mg/l
6.8
7.8
0.70
53
201
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
114
441
2.61
20.01
1.6
1.5
u/l
5.3
5.4
0.04
58
209
(3039000) Anion gap in Blood
275
1515
1.84
19.78
11.4
6.9
mmol/l
11.4
11.2
0.54
236
1354
(3018572) Chloride [Moles/volume] in Blood
275
1516
1.84
19.73
11.4
6.9
mmol/l
104.9
105.2
0.47
236
1355
(3023410) Appearance of Cerebral spinal fluid
157
710
2.23
19.53
3.7
1.7
—
—
—
0
0
(4268621)
161
736
2.21
19.51
2.3
2.3
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
96
345
2.80
19.45
1.4
1.3
%
32.8
65.9
—
6
44
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
78
250
3.14
19.34
1.4
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
199
1002
2.01
18.74
1.2
1.2
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
19
16
11.90
18.68
8.1
10.1
—
—
—
0
0
(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid
18
14
12.88
18.54
8.1
8.9
%
38.1
56.7
—
10
6
(3023183) Ammonium ion [Moles/volume] in Plasma
267
1489
1.82
18.48
2.9
3.0
umol/l
30.5
35.1
2.56
235
1278
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
140
620
2.28
18.34
2.9
2.9
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
170
819
2.10
18.06
1.6
1.4
g/l
31.0
33.3
1.38
152
742
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
88
315
2.81
17.99
2.4
1.8
%
161.0
145.9
0.63
80
298
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
127
545
2.35
17.90
1.5
1.3
mmol/l
2.2
2.0
0.59
122
513
(3011985) Renin [Units/volume] in Plasma
185
923
2.03
17.89
1.4
1.5
mu/l
92.0
67.8
0.43
163
826
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
200
1027
1.97
17.84
1.1
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
60
172
3.51
17.80
1.4
1.1
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
44
102
4.33
17.51
1.8
1.1
ng/l
48.6
83.9
0.53
33
68
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
81
284
2.87
17.22
1.1
1.1
ng/l
690.5
356.0
0.32
22
65
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
40
88
4.56
17.00
1.1
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
206
1087
1.92
16.98
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
97
379
2.58
16.75
1.2
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
46
115
4.02
16.60
2.3
1.6
ng/l
146.9
132.5
0.21
46
115
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
2153
18174
1.25
16.45
1.8
1.7
mmol/l
1.5
1.4
6.36
1842
15349
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
18
17
10.61
16.43
3.3
4.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
122
538
2.29
16.19
1.2
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
181
930
1.97
16.16
1.7
1.6
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
32
61
5.26
16.04
1.2
1.3
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
44
110
4.02
15.89
1.3
1.0
pmol/l
4.2
5.9
—
7
12
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
33
66
5.02
15.69
3.3
4.0
mg/l
1.7
1.1
0.40
25
43
(3002256) Pathology report gross observation
1129
8837
1.32
15.67
1.3
1.3
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
197
1056
1.89
15.52
1.2
1.1
%
122.0
116.9
1.01
179
954
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
47
126
3.75
15.42
1.3
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
73
259
2.83
15.24
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
132
619
2.15
15.11
1.7
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
137
653
2.12
15.05
1.5
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
160
810
1.99
14.93
1.7
1.6
%
53.7
57.3
0.48
95
517
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
23
34
6.78
14.84
5.5
5.1
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
31
62
5.01
14.75
1.0
1.2
mg/l
14.9
10.0
0.82
23
56
(3014765) Yersinia sp identified in Stool by Organism specific culture
314
1954
1.63
14.69
1.3
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
6951
66488
1.28
14.68
5.3
4.4
mmol/l
6.0
5.9
6.35
6533
61058
(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method
16
15
10.69
14.64
1.0
1.1
u/field
1.0
1.1
—
10
10
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
25
41
6.11
14.64
1.2
1.0
u/l
1.9
5.3
—
9
9
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
155
784
2.00
14.52
1.2
1.1
%
100.0
97.2
0.58
144
738
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
168
874
1.94
14.51
1.2
1.4
pmol/l
429.3
333.9
0.49
121
669
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
311
1937
1.63
14.50
1.3
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
36
83
4.35
14.47
1.3
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
62
207
3.01
14.44
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
2180
18672
1.23
14.15
1.5
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
313
1965
1.62
14.14
1.3
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
146
731
2.02
14.08
1.6
1.4
e6/l
1897.4
2314.2
0.60
109
536
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
892
6861
1.34
13.90
3.5
4.2
ug/l
14.7
29.4
1.22
675
5533
(3045424) Erythrocytes [Presence] in Urine
201
1131
1.80
13.61
1.7
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
177
958
1.87
13.59
1.6
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
125
606
2.08
13.19
1.6
1.5
%
29.7
30.4
0.08
76
371
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
39
103
3.80
13.12
1.4
1.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
192
1078
1.80
13.11
1.2
1.1
au/ml
13.3
11.2
0.13
13
60
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
622
4573
1.39
12.92
1.3
1.2
iu/ml
112.0
144.7
1.59
237
1727
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
56
189
2.98
12.85
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
51
163
3.14
12.84
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
51
163
3.14
12.84
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
51
163
3.14
12.84
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
51
163
3.14
12.84
1.1
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
130
649
2.02
12.69
1.6
1.4
e6/l
49628.5
63904.5
0.22
77
379
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
55
186
2.97
12.58
1.2
1.1
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
96
430
2.25
12.39
1.4
1.3
u/l
14.5
13.0
0.32
90
398
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
89
386
2.32
12.39
1.3
1.2
—
—
—
0
0
(4306422)
190
1084
1.77
12.32
1.2
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
72
284
2.55
12.31
1.1
1.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
64
238
2.70
12.31
6.6
6.6
mmol/l
24.2
24.9
0.67
57
219
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
19
28
6.80
12.29
2.9
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
200
1160
1.74
12.25
1.6
1.4
mmol/l
65.5
63.8
0.22
168
931
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
55
189
2.92
12.24
1.1
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
7892
77159
1.45
12.24
39.2
20.1
e9/l
249.2
252.3
3.78
7791
75275
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
80
334
2.41
12.14
1.9
1.7
u/field
6.7
2.7
0.94
65
239
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
52
174
3.00
12.13
1.2
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
347
2314
1.52
12.09
2.3
2.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
56
196
2.87
12.07
1.1
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
307
1995
1.56
12.03
1.3
1.3
miu/ml
205.5
222.7
0.28
97
911
(3023323) Follitropin [Units/volume] in Serum or Plasma
461
3266
1.44
11.84
1.8
1.4
iu/l
25.1
29.4
2.03
387
2795
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
92
413
2.24
11.83
1.1
1.1
nmol/l
2.0
10.2
1.19
17
86
(3035941) MCH [Entitic mass]
7893
77212
1.44
11.77
38.9
20.0
pg
30.1
30.3
10.30
7843
76211
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
75
310
2.43
11.65
1.5
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
75
310
2.43
11.65
1.5
1.5
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
7893
77224
1.44
11.63
39.1
20.1
e12/l
4.5
4.5
9.14
7781
75132
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
175
992
1.78
11.62
1.2
1.3
nmol/l
0.6
2.2
0.73
168
958
(3024731) MCV [Entitic volume]
7892
77214
1.44
11.62
39.0
20.0
fl
90.8
90.9
1.24
7843
76215
(3002621) Streptococcal DNAse B [Units/volume] in Serum
31
76
4.09
11.56
1.1
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
6664
63827
1.22
11.55
27.7
14.6
%
39.6
40.1
5.45
4839
47234
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
84
368
2.30
11.46
3.8
5.9
u/ml
49.0
8826.1
—
5
80
(3000963) Hemoglobin [Mass/volume] in Blood
7893
77241
1.43
11.44
39.4
20.2
g/l
134.0
136.3
33.22
7843
76240
(3020393) Adenovirus Ag [Presence] in Stool
37
104
3.57
11.42
2.1
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
47
154
3.06
11.39
1.1
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
175
999
1.77
11.36
1.2
1.3
nmol/l
0.2
0.3
—
8
60
(3040151) Glucose [Moles/volume] in Capillary blood
136
718
1.91
11.35
5.6
14.0
mmol/l
7.5
7.4
0.11
116
597
(3032743) Legionella sp IgG Ab [Presence] in Serum
22
41
5.38
11.33
1.2
1.0
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
7892
77242
1.43
11.30
39.2
20.1
e9/l
6.8
6.7
1.50
7773
75133
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
34
91
3.75
11.26
1.8
1.6
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
53
188
2.83
11.17
1.2
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
64
251
2.56
11.12
1.5
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
160
897
1.80
11.05
1.2
1.3
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
22
42
5.25
11.04
1.2
1.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
462
3323
1.41
10.92
1.1
1.1
titre
171.5
220.4
0.23
13
95
(3004451) EKG impression Narrative
77
332
2.33
10.91
1.3
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
92
428
2.16
10.88
1.1
1.1
ratio
1.1
1.1
0.37
32
143
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
49
171
2.88
10.66
1.6
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
186
1104
1.70
10.55
1.3
1.1
iu/ml
71.1
9313.9
0.56
39
261
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
19
33
5.77
10.52
1.1
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
29
73
3.98
10.46
1.2
1.1
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
12
12
10.01
10.44
1.2
1.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
181
1071
1.71
10.39
1.2
1.3
u/l
58.4
39.1
0.49
166
935
(3045414) Leukocytes [Presence] in Urine
422
3017
1.42
10.33
2.3
1.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
121
637
1.91
10.23
1.2
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
90
426
2.12
10.21
1.6
1.4
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
43
143
3.02
10.19
1.1
1.2
%
97.0
77.9
2.30
15
43
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
43
143
3.02
10.19
1.1
1.2
%
75.7
73.5
0.10
13
42
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
88
415
2.13
10.09
1.6
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
110
565
1.96
10.01
1.1
1.0
mg/l
306.3
283.3
2.12
102
509
(3027456) Digoxin [Moles/volume] in Serum or Plasma
181
1086
1.68
9.89
3.2
3.0
nmol/l
0.9
0.8
0.55
127
827
(40763590) HLA-DQ beta [Type]
16
25
6.41
9.80
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
16
25
6.41
9.80
1.0
1.0
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
76
342
2.23
9.79
1.2
1.1
u/ml
7.4
18.6
—
8
31
(36660697) Celiac disease serology panel - Serum
704
5504
1.30
9.70
1.2
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
28
73
3.85
9.65
1.2
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
25
60
4.18
9.61
1.2
1.1
—
—
—
0
0
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
17
29
5.87
9.58
1.1
1.2
u/field
1.5
1.0
0.44
11
21
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
29
78
3.73
9.57
1.3
1.2
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
11
11
10.01
9.54
1.1
1.1
mg/l
2.3
1.1
2.31
11
11
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
77
353
2.19
9.50
1.1
1.1
u/l
103.5
87.0
0.71
63
281
(3036782) Glucose [Moles/volume] in Pleural fluid
111
583
1.92
9.48
1.5
1.3
mmol/l
7.0
6.3
1.75
105
539
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
470
3477
1.37
9.43
2.5
2.4
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
115
617
1.88
9.22
1.6
1.4
e6/l
177954.3
97643.4
0.50
92
419
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
69
308
2.25
9.10
5.0
3.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
107
564
1.91
9.06
1.6
1.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
35
112
3.13
8.89
1.3
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
171
1042
1.65
8.85
1.5
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
6814
65815
1.20
8.71
4.6
3.9
mmol/l
1.4
1.3
29.29
6381
60722
(40760409) HLA-A [Type] by High resolution
15
25
6.01
8.64
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
15
25
6.01
8.64
1.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
117
645
1.83
8.64
1.7
1.5
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
18
36
5.01
8.60
1.7
1.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
685
5427
1.29
8.53
2.6
2.2
nmol/l
12.5
13.0
1.09
602
4824
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
91
464
1.97
8.52
1.6
1.5
u/ml
21.3
19.7
0.17
21
97
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
23
57
4.04
8.50
1.4
1.4
ml/s/173m2
1.4
1.0
0.61
16
40
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
37
126
2.95
8.47
1.8
1.7
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
12
16
7.51
8.41
5.4
4.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
829
6737
1.26
8.37
1.5
1.4
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
74
352
2.11
8.37
1.1
1.1
u/l
39.1
24.7
1.02
64
267
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
54
225
2.41
8.36
1.6
1.2
%
24.8
25.7
—
10
32
(3013862) HLA-DP [Type]
15
26
5.78
8.32
1.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
76
367
2.08
8.27
1.8
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
41
150
2.74
8.25
1.1
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
333
2381
1.42
8.21
3.3
3.6
u/ml
629.2
2465.0
0.87
285
2043
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
53
221
2.41
8.20
1.2
1.1
%
84.3
89.5
0.41
20
114
(3045683) HLA typing for celiac disease panel - Blood or Tissue
81
403
2.02
8.14
1.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
55
235
2.35
8.07
1.2
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
28
83
3.38
8.05
1.4
1.3
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
12
17
7.07
7.99
1.2
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
7060
68538
1.20
7.88
5.1
4.3
mmol/l
4.6
4.7
13.60
6687
63961
(3008037) Lactate [Moles/volume] in Venous blood
205
1344
1.54
7.86
3.6
3.0
mmol/l
1.6
1.6
0.18
199
1304
(3035880) pH of Pleural fluid
71
341
2.09
7.86
1.4
1.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
135
800
1.70
7.82
1.6
2.1
ug/l
21.5
24.6
0.35
129
788
(3021387) Prolactin [Units/volume] in Serum or Plasma
313
2234
1.42
7.82
1.8
1.7
mu/l
318.6
300.4
0.46
295
2030
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
157
968
1.63
7.82
1.6
1.4
nmol/l
0.3
0.4
0.61
123
725
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
56
245
2.29
7.80
1.2
1.1
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
27
80
3.38
7.78
1.7
1.4
ug/l
116.0
123.0
0.12
21
67
(21494755) Public health laboratory ask at order entry panel
578
7296
0.78
7.75
1.3
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
109
610
1.80
7.71
1.0
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
45
179
2.52
7.71
1.8
1.9
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
51
216
2.37
7.65
1.2
1.2
%
81.1
88.7
0.42
19
114
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
211
1401
1.52
7.64
2.4
2.0
nmol/l
1.1
0.8
3.19
180
1185
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
11
6
18.35
7.59
1.2
1.0
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
74
366
2.03
7.59
1.2
1.4
nmol/l
1.2
1.2
0.11
51
283
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
25
72
3.48
7.52
1.2
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
42
164
2.57
7.48
2.1
1.8
mmol/l
0.2
0.7
0.39
36
156
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
46
188
2.45
7.46
6.9
7.0
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
110
624
1.77
7.45
1.2
1.3
nmol/l
1.6
1.5
0.52
100
559
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
7010
68083
1.19
7.40
5.0
4.3
mmol/l
1.4
1.5
38.77
6587
63218
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
30
99
3.04
7.29
1.1
1.1
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
14
26
5.39
7.24
1.2
1.0
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
19
6.32
7.24
4.5
7.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
33
116
2.85
7.19
1.0
1.1
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
44
180
2.45
7.14
1.5
1.4
%
76.5
73.1
1.45
44
174
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
7159
69701
1.20
7.13
5.5
4.8
mmol/l
2.7
2.8
13.35
6732
64670
(3034891) Synovial lining cells/100 cells in Synovial fluid
65
314
2.08
7.13
1.6
1.5
%
6.9
3.8
0.66
16
77
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
88
473
1.87
7.12
1.1
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
57
264
2.17
6.97
1.2
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
121
721
1.69
6.92
2.6
2.3
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
43
177
2.44
6.90
1.6
1.4
mu/l
513.2
460.6
0.22
43
171
(3019174) dRVVT (LA screen)
22
62
3.56
6.85
1.1
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
30
103
2.92
6.83
2.8
3.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
198
1331
1.50
6.81
1.8
1.8
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
451
3486
1.31
6.81
3.2
3.5
u/ml
46.7
55.1
0.44
428
3360
(3001686) Cold agglutinin [Titer] in Serum or Plasma
33
120
2.76
6.78
1.3
1.3
titre
16.7
120.8
—
6
20
(3035285) Chloride [Moles/volume] in Venous blood
123
741
1.67
6.76
2.6
2.2
mmol/l
105.6
105.3
0.32
123
730
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
17
40
4.26
6.74
1.1
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
123
742
1.67
6.73
2.6
2.2
mmol/l
4.0
4.1
0.09
123
731
(3038515) Glucose [Moles/volume] in Venous blood
189
1264
1.51
6.67
3.7
3.1
mmol/l
7.4
7.5
0.09
184
1231
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
42
175
2.41
6.58
3.4
2.5
ng/l
105.2
154.1
0.83
29
90
(3033923) Metanephrine [Moles/time] in 24 hour Urine
35
134
2.62
6.53
1.0
1.1
umol/24h
0.6
0.7
0.76
22
61
(3025018) Bordetella pertussis Ab [Titer] in Serum
78
416
1.88
6.50
1.2
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
67
340
1.98
6.46
1.5
1.5
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
11
18
6.12
6.42
1.1
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
37
147
2.52
6.41
1.4
1.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
89
498
1.80
6.38
1.8
2.0
u/field
2.0
2.0
0.04
55
200
(3004716) Salmonella sp identified in Stool by Organism specific culture
435
3379
1.30
6.36
1.3
1.4
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
17
42
4.05
6.34
1.6
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
41
172
2.39
6.34
1.2
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
18
47
3.84
6.25
1.2
1.0
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
82
451
1.83
6.23
1.0
1.1
iu/ml
6.0
10.5
1.39
12
113
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
537
6657
0.79
6.19
1.7
1.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
34
132
2.58
6.18
1.4
1.3
—
—
—
0
0
(4034850)
299
2208
1.37
6.18
13.0
9.4
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
23
72
3.20
6.13
1.2
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
45
201
2.25
6.05
1.1
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
21
63
3.34
5.98
1.0
1.2
umol/24h
1.6
1.7
0.34
21
63
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
10
16
6.26
5.95
1.2
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
25
84
2.98
5.94
1.1
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
16
40
4.01
5.89
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
53
256
2.08
5.88
1.2
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
229
1635
1.41
5.81
1.8
1.8
iu/l
4.9
4.6
0.16
77
605
(3036071) Salmonella sp Ab [Titer] in Serum
51
244
2.10
5.81
1.1
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
23
75
3.07
5.75
1.3
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
256
1868
1.38
5.73
1.1
1.1
u/ml
9.4
7.3
0.20
34
232
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
25
86
2.91
5.71
1.1
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
16
41
3.91
5.70
1.1
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
39
169
2.31
5.65
7.4
7.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
100
602
1.67
5.59
1.7
1.4
ug/l
5.2
3.8
0.34
87
501
(3023511) Choriogonadotropin [Units/volume] in Urine
150
997
1.51
5.53
1.3
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
37
159
2.33
5.47
1.4
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
269
1997
1.36
5.43
2.1
2.2
u/l
4412.5
4400.2
0.00
86
755
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
48
231
2.08
5.41
1.6
1.4
%
63.1
64.4
0.09
37
188
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
28
106
2.65
5.39
1.2
1.4
nmol/l
5.9
375869.2
0.91
23
87
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
201
1425
1.42
5.34
3.0
3.6
u/ml
240.3
593.7
0.78
179
1308
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
337
2597
1.31
5.28
1.6
1.7
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
105
651
1.62
5.26
2.3
2.4
umol/l
8.7
9.0
0.05
81
472
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
11
22
5.01
5.25
1.0
1.2
u/field
0.8
1.1
—
6
13
(3052592) Norovirus Ag [Presence] in Stool
31
126
2.47
5.19
1.6
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
38
170
2.24
5.15
1.1
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
37
164
2.26
5.12
1.1
1.2
pmol/l
365.3
279.3
0.45
27
121
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
145
974
1.50
5.12
1.1
1.1
u/ml
3.3
3.2
0.02
44
450
(3024263) Appearance of Synovial fluid
68
377
1.81
5.11
2.5
1.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
76
436
1.75
5.09
2.5
1.7
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
25
92
2.72
5.09
1.2
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
21
70
3.01
5.09
5.5
3.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
872
7488
1.18
5.07
1.6
1.6
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
104
650
1.61
5.06
4.2
4.9
u/ml
79.6
75.4
0.04
37
190
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
37
165
2.25
5.05
1.2
1.2
ug/l
207.4
337.0
0.27
19
87
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
11
23
4.79
5.01
1.0
1.1
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
35
154
2.28
4.94
1.5
1.4
%
24.0
24.4
0.03
29
131
(3035320) C reactive protein [Mass/volume] in Body fluid
83
493
1.69
4.93
3.1
2.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
348
4413
0.78
4.90
1.4
1.4
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
38
174
2.19
4.89
1.7
1.4
%
22.5
23.4
0.06
31
157
(3013293) Extractable nuclear Ab [Presence] in Serum
27
106
2.55
4.86
1.7
1.6
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
14
37
3.79
4.80
1.1
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
18
57
3.16
4.75
2.1
2.6
u/field
0.5
0.7
0.27
18
57
(3044009) aPTT.lupus sensitive (LA screen)
18
58
3.11
4.63
1.1
1.2
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
40
192
2.09
4.59
1.7
1.4
%
2.0
2.5
0.19
32
160
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
11
25
4.40
4.56
1.0
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
64
362
1.77
4.54
3.3
2.9
ph
7.4
7.4
0.00
18
126
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
116
765
1.52
4.52
1.3
1.3
—
31.1
—
0
8
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
45
228
1.98
4.48
2.6
2.1
mg/l
8.9
9.4
0.28
40
187
(44813793)
81
492
1.65
4.46
1.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
390
3133
1.26
4.45
1.1
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
119
794
1.51
4.40
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
162
1150
1.42
4.36
1.2
1.1
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
11
26
4.24
4.35
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
162
1152
1.41
4.32
1.2
1.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
15
45
3.34
4.32
1.2
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
61
346
1.77
4.31
1.4
1.3
nmol/l
137.7
136.8
0.05
61
346
(3016038) Potassium [Moles/volume] in Urine
75
451
1.67
4.31
1.5
1.3
mmol/l
27.4
35.6
3.22
66
393
(3010015) Selenium [Moles/volume] in Serum or Plasma
20
72
2.78
4.27
2.5
2.2
umol/l
1.2
1.3
0.65
20
64
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
7
6
11.68
4.27
1.0
1.0
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
37
178
2.08
4.25
1.3
1.3
nmol/l
127.7
128.0
0.00
28
137
(3000034) Microalbumin [Mass/volume] in Urine
98
632
1.56
4.24
4.3
2.9
mg/l
218.5
45.8
1.60
76
467
(3018851) Theophylline [Moles/volume] in Serum or Plasma
17
56
3.04
4.23
2.5
1.6
umol/l
46.0
41.8
0.34
17
56
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
39
192
2.04
4.22
3.5
3.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
39
192
2.04
4.22
3.5
3.0
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
35
166
2.11
4.17
1.4
1.6
ug/l
0.4
0.4
0.06
25
107
(3023383) Lactate [Moles/volume] in Pleural fluid
38
187
2.04
4.12
1.5
1.3
mmol/l
3.6
3.5
0.12
38
170
(3044242) Glucose [Moles/volume] in Arterial blood
56
316
1.78
4.05
2.9
2.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
23
93
2.48
3.95
1.7
2.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
175
1283
1.37
3.93
1.1
1.1
u/ml
5.1
5.3
0.05
102
662
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
20
76
2.64
3.89
1.1
1.1
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
10
24
4.17
3.88
1.1
1.0
—
—
—
0
0
(44806071)
23
95
2.42
3.79
1.0
1.1
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
54
308
1.76
3.79
1.9
1.4
umol/l
3.2
4.2
1.36
48
287
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
36
181
1.99
3.72
2.1
1.7
au/ml
109.1
110.2
—
7
20
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
22
90
2.45
3.70
1.3
1.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
17
61
2.79
3.68
1.1
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
110
756
1.46
3.59
1.7
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
189
1425
1.33
3.58
1.1
1.1
u/ml
1.8
1.6
0.07
91
592
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
23
98
2.35
3.56
1.4
1.4
%
5.9
10.0
0.69
15
51
(3036670) Protein [Mass/volume] in Synovial fluid
37
194
1.91
3.42
1.4
1.2
g/l
40.2
39.6
0.10
17
109
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
48
274
1.76
3.40
3.1
2.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
32
160
2.00
3.38
1.4
1.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
117
824
1.43
3.38
1.7
1.7
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
14
48
2.92
3.29
1.5
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
9
20
4.50
3.11
1.0
1.0
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
40
223
1.80
3.09
3.1
1.9
e6/l
15556.6
13303.8
0.07
23
123
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
38
209
1.82
3.07
1.2
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
51
306
1.67
3.06
2.8
2.2
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
6
8
7.51
3.05
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
381
3194
1.20
3.01
5.1
3.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
27
133
2.03
3.00
2.9
1.9
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
30
154
1.95
2.98
1.8
1.3
g/l
27.6
26.0
0.17
21
115
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
5
5
10.00
2.98
1.0
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
26
127
2.05
2.96
8.2
7.2
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
44
257
1.72
2.92
1.3
1.5
pmol/l
21.4
15.2
0.98
39
217
(3033799) Differential panel - Peritoneal fluid
39
220
1.78
2.92
2.2
1.9
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
26
129
2.02
2.85
2.2
1.6
nmol/l
0.1
0.2
0.73
20
84
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2292
21591
1.08
2.79
4.4
4.6
ug/l
2.4
2.9
0.90
2076
19518
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
15
59
2.55
2.78
3.6
1.9
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
58
370
1.57
2.76
2.0
2.5
umol/l
58.5
27.1
0.61
11
34
(3042010) Triglyceride [Moles/volume] in Pleural fluid
21
97
2.17
2.76
1.3
1.3
mmol/l
0.3
2.1
1.65
13
65
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
12
42
2.86
2.74
1.0
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
50
309
1.62
2.72
3.8
2.2
mmol/l
8.5
9.3
0.75
35
240
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
911
8219
1.12
2.70
4.7
4.4
%
31.6
32.0
0.59
715
5650
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
15
60
2.50
2.69
1.1
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
15
60
2.50
2.69
1.2
1.0
—
—
—
0
0
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
11
37
2.98
2.69
1.0
1.1
u/ml
0.0
0.1
—
5
17
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
51
318
1.61
2.68
1.1
1.1
u/ml
14.3
6.7
0.52
15
55
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
8
19
4.21
2.67
1.1
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
25
126
1.99
2.64
1.2
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
25
126
1.99
2.64
1.2
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
25
126
1.99
2.64
1.2
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
201
1601
1.26
2.62
2.0
1.9
pmol/l
193.1
203.6
0.81
184
1518
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
14
55
2.55
2.61
1.2
1.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
154
1187
1.30
2.60
1.1
1.1
u/ml
4.9
2.3
0.51
39
284
(44816559) Phosphatidylethanol [Mass/volume] in Blood
175
1373
1.28
2.59
1.3
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
764
6842
1.13
2.57
1.9
2.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
160
1242
1.29
2.57
1.1
1.1
u/ml
1.4
1.1
0.12
81
538
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
23
115
2.00
2.50
1.2
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
26
136
1.91
2.49
2.0
2.5
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
51
325
1.57
2.47
1.1
1.1
%
91.8
95.8
0.44
42
255
(3027570) Oxalate [Moles/time] in 24 hour Urine
12
45
2.67
2.44
1.1
1.6
umol/24h
257.2
337.2
1.34
12
45
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
67
455
1.48
2.44
1.3
1.5
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
18
83
2.17
2.40
1.1
1.2
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
6
12
5.00
2.40
1.3
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
23
117
1.97
2.39
2.7
2.7
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
121
921
1.32
2.28
1.1
1.1
u/ml
3.1
4.3
0.45
52
367
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
12
47
2.56
2.26
6.1
4.6
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
19
92
2.07
2.26
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
319
3733
0.85
2.20
1.7
1.7
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
45
288
1.57
2.18
2.2
2.5
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
26
143
1.82
2.18
2.2
2.2
mmol/l
7.2
7.6
0.26
16
83
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
8
24
3.34
2.18
1.0
1.0
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
40
249
1.61
2.17
3.4
2.0
e6/l
11999.9
3898.6
0.31
29
172
(3003338) MCHC [Mass/volume]
6084
59673
1.07
2.16
33.5
17.4
g/l
331.8
332.7
11.32
6058
59262
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
683
6162
1.12
2.07
1.8
1.9
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
5
10
5.00
2.07
1.0
1.2
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
22
117
1.88
2.05
2.0
2.4
mmol/l
1.1
1.5
0.23
14
87
(3049233) Organic acids panel - Urine
6
15
4.00
2.04
1.0
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
47
311
1.51
1.99
3.0
2.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
485
4299
1.14
1.98
3.5
2.8
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
8
27
2.96
1.93
1.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
25
142
1.76
1.92
1.6
2.6
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
27
157
1.72
1.92
1.1
1.3
mu/l
339.6
55.9
0.54
21
124
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
205
2458
0.83
1.91
1.8
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
189
1559
1.22
1.89
5.2
4.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
8
28
2.86
1.86
1.4
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
330
2863
1.16
1.85
1.8
1.8
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
103
795
1.30
1.83
2.7
2.1
mg/l
23.3
22.9
0.03
36
211
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
48
326
1.48
1.82
1.6
1.7
nmol/l
3.9
5.4
0.35
40
267
(3022689) Creatine [Moles/volume] in Urine
33
206
1.60
1.82
1.7
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
125
991
1.27
1.80
1.1
1.1
u/ml
5.6
4.0
0.32
58
387
(3013139) Helicobacter pylori Ag [Presence] in Stool
508
4556
1.12
1.75
1.2
1.2
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
16
81
1.98
1.74
1.1
1.2
u/ml
0.0
0.5
—
9
48
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
9
36
2.50
1.73
1.2
1.0
u/l
29.4
53.2
—
9
29
(3013336) Amino acids [Identifier] in Serum or Plasma
7
24
2.92
1.72
1.6
3.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
145
1180
1.23
1.69
1.1
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
892
8253
1.09
1.68
11.5
6.7
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
25
149
1.68
1.66
1.3
1.2
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
5
14
3.57
1.61
1.0
1.1
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
5
14
3.57
1.61
6.2
6.8
mmol/l
0.2
0.2
—
5
14
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
18
98
1.84
1.61
1.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
50
354
1.41
1.57
1.2
1.2
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
18
99
1.82
1.57
1.2
1.3
%
60.8
59.2
—
10
41
(3008295) Osmolality of Serum or Plasma
89
693
1.29
1.53
1.7
1.4
mosm/kgh2o
280.7
279.6
0.14
68
541
(3004347) Hepatitis D virus Ab [Presence] in Serum
5
15
3.33
1.52
1.0
1.0
—
—
—
0
0
(4094501)
224
1921
1.17
1.52
1.1
1.1
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
21
123
1.71
1.50
1.3
1.2
mmol/l
1.2
1.8
1.96
15
78
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
24
146
1.65
1.50
2.9
4.6
u/l
47.0
66.3
—
5
50
(3051593) INR in Capillary blood by Coagulation assay
42
291
1.45
1.49
6.9
10.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
406
3634
1.12
1.49
1.9
1.9
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
27
170
1.59
1.48
1.3
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
32
211
1.52
1.45
1.3
1.2
—
—
—
0
0
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
7
28
2.50
1.45
1.0
1.0
u/ml
0.0
0.3
—
7
20
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
29
187
1.55
1.45
1.0
1.0
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
5
16
3.13
1.44
3.8
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
178
1506
1.19
1.43
3.1
2.2
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
15
81
1.85
1.39
1.5
1.2
mmol/l
5.1
5.8
—
7
43
(3020874) Milk IgE Ab [Units/volume] in Serum
58
433
1.34
1.37
1.0
1.1
u/ml
0.4
2.3
1.54
18
137
(3017937) Magnesium [Moles/time] in 24 hour Urine
6
23
2.61
1.36
1.3
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
21
127
1.66
1.36
1.0
1.1
—
—
—
0
0
(4281824)
93
744
1.25
1.32
1.3
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
12
61
1.97
1.32
1.2
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
58
436
1.33
1.32
6.6
6.6
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
30
201
1.49
1.29
3.9
1.9
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
30
201
1.49
1.29
1.1
1.1
u/ml
0.2
5.7
0.75
17
114
(40763480) Human metapneumovirus Ag [Presence] in Specimen
8
34
2.35
1.29
1.1
1.4
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
65
499
1.30
1.28
1.5
1.8
mmol/l
7.3
6.6
0.96
51
342
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
123
1019
1.21
1.28
1.5
1.3
u/l
29.6
28.6
0.13
108
827
(4146454)
86
687
1.25
1.25
2.8
2.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
949
8924
1.07
1.23
1.7
1.8
%
1.5
1.5
1.47
827
7888
(3032868) Hemoglobin electrophoresis panel in Blood
14
78
1.80
1.21
1.7
1.5
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
44
322
1.37
1.20
1.6
2.2
umol/l
96.3
147.8
1.00
24
166
(3013762) Body weight Measured
6
26
2.31
1.18
1.0
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
392
3557
1.11
1.18
1.0
1.1
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
8
38
2.11
1.18
1.0
1.7
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
11
57
1.93
1.16
1.3
1.1
u/l
5.2
15.6
1.34
11
57
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
33
0.00
1.16
0.0
1.4
—
24.6
—
0
33
(3027974) Hepatitis B virus e Ag [Presence] in Serum
8
39
2.05
1.15
1.0
1.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
32
224
1.43
1.14
1.4
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
119
1414
0.84
1.12
1.6
1.6
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
10
51
1.96
1.11
12.7
4.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
69
547
1.26
1.10
1.3
1.3
mmol/l
10.6
12.1
1.10
32
153
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
13
73
1.78
1.10
1.1
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
21
316
0.66
1.08
1.7
1.5
mmol/l
7.8
8.0
0.10
16
198
(3020650) Glucose [Presence] in Urine
27
185
1.46
1.08
1.2
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
41
306
1.34
1.03
1.7
2.5
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
132
1128
1.17
1.03
3.0
3.8
u/ml
23.7
30.7
0.83
126
1097
(3005011) Chlamydia sp Ab [Titer] in Serum
18
114
1.58
1.02
1.4
1.6
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
7
35
2.00
1.00
1.0
1.1
—
—
—
0
0
(21494227) Amikacin free [Mass/volume] in Serum or Plasma
5
23
2.17
0.98
8.0
5.2
mg/l
20.2
3.2
—
5
15
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
21
141
1.49
0.94
1.9
2.0
ug/l
1.9
2.0
0.04
14
73
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
9
51
1.77
0.94
1.2
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
161
1409
1.15
0.94
4.6
3.3
mg/l
25.2
26.5
0.21
103
871
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
20
134
1.49
0.91
1.3
1.3
mg/l
0.4
83.6
1.01
12
99
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
44
340
1.30
0.90
2.3
2.0
ug/min
325.5
167.7
0.47
12
83
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
29
210
1.38
0.90
1.7
1.5
ug/l
9.8
8.8
0.36
29
210
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
6
29
2.07
0.89
1.2
1.4
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
49
386
1.27
0.87
1.0
1.1
u/ml
0.1
1.5
—
5
66
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
8
43
1.86
0.87
1.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
21
144
1.46
0.87
1.1
1.1
u/ml
54.3
58.6
0.11
21
136
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1081
10336
1.05
0.86
1.5
1.4
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
51
405
1.26
0.86
2.1
2.0
ug/l
8.1
3.4
0.69
43
351
(3014599) Egg white IgE Ab [Units/volume] in Serum
54
433
1.25
0.84
1.0
1.1
u/ml
9.2
2.5
0.34
20
124
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
6
32
1.88
0.81
1.2
1.2
nmol/l
222.3
318.7
—
6
32
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
20
139
1.44
0.79
2.6
6.4
%
62.3
71.9
0.74
14
112
(3025577) Chromium [Mass/volume] in Blood
49
393
1.25
0.78
2.1
2.1
ug/l
3.3
2.4
0.50
42
332
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
26
191
1.36
0.76
1.1
1.0
u/ml
13.7
5.6
—
8
21
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1776
17226
1.04
0.76
3.8
4.0
%
22.6
21.8
1.26
813
7934
(3014891) Appearance of Pleural fluid
13
83
1.57
0.74
2.2
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
111
1271
0.87
0.74
1.3
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
27
358
0.75
0.74
1.2
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
26
193
1.35
0.73
1.0
1.0
—
—
—
0
0
(4024509)
75
635
1.18
0.72
2.1
1.5
—
—
—
0
0
(4212803)
10
61
1.64
0.68
1.0
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
9
59
1.53
0.68
1.4
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
237
2579
0.92
0.66
1.9
2.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
36
285
1.26
0.66
1.1
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
37
294
1.26
0.66
2.5
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
236
2566
0.92
0.65
1.9
2.1
—
—
—
0
0
(4038314)
7
44
1.59
0.65
1.0
1.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
11
70
1.57
0.65
2.3
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
238
2586
0.92
0.65
1.9
2.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
240
2209
1.09
0.64
1.5
1.4
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
12
79
1.52
0.62
1.2
1.3
nmol/l
15.0
13.6
—
5
19
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
10
64
1.56
0.58
2.4
2.1
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
105
1181
0.89
0.58
1.5
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
28
354
0.79
0.57
1.3
1.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
5
90
0.56
0.55
1.2
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
155
1696
0.91
0.53
2.3
3.2
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
9
62
1.45
0.53
1.1
1.0
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
13
91
1.43
0.52
6.0
3.1
umol/l
28.6
40.3
1.68
13
73
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
9
63
1.43
0.52
1.9
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
236
2533
0.93
0.51
1.8
2.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
81
714
1.14
0.51
1.2
1.3
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
9
64
1.41
0.51
1.2
2.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
29
233
1.25
0.50
1.6
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
45
531
0.85
0.50
1.1
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
2512
25560
0.98
0.49
3.1
2.8
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
57
492
1.16
0.49
1.6
1.4
umol/l
70.1
69.9
—
7
38
(3041672) Baker's yeast Ab [Presence] in Serum
7
47
1.49
0.47
1.1
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
12
86
1.40
0.44
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
123
1342
0.92
0.43
1.6
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
84
933
0.90
0.42
1.5
1.5
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
92
832
1.11
0.41
1.0
1.1
u/ml
1.8
0.6
0.32
26
195
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
12199.2
—
0
6
(3022670) pH of Venous cord blood
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
225
2383
0.94
0.37
1.9
2.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
100
1092
0.91
0.37
1.4
1.4
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
8
112
0.71
0.37
1.0
1.1
ug/l
89.5
79.1
—
8
91
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
100
1091
0.92
0.37
1.4
1.4
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
16
125
1.28
0.36
1.0
1.1
u/ml
0.0
10.9
—
9
94
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
100
1090
0.92
0.36
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
100
1089
0.92
0.36
1.4
1.4
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
22
180
1.22
0.35
1.4
1.3
%
40.0
36.0
—
9
120
(3006462) Nitrate [Presence] in Urine
36
310
1.16
0.35
2.7
3.3
—
—
—
0
0
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
6
43
1.40
0.35
1.2
1.3
u/l
28.3
1865.0
—
6
37
(3041806) Other cells [#/volume] in Blood by Manual count
19
154
1.23
0.33
2.2
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
53
472
1.12
0.33
2.0
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
42
369
1.14
0.32
1.2
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
11
83
1.33
0.32
1.1
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
121
1127
1.07
0.31
2.3
3.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
7
54
1.30
0.30
1.0
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
62
564
1.10
0.28
1.2
1.2
nmol/l
359.0
371.0
0.20
50
488
(3005033) Fetal Nuchal fold Thickness US
83
897
0.92
0.27
1.4
1.4
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
8
64
1.25
0.27
1.4
1.3
umol/l
80.7
85.8
—
8
59
(4211845)
38
337
1.13
0.27
2.7
3.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
66
719
0.92
0.26
1.4
1.4
—
—
—
0
0
(4198724)
28
321
0.87
0.26
1.6
2.3
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
5
75
0.67
0.25
1.0
1.7
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
9
72
1.25
0.25
1.0
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
66
608
1.09
0.24
1.2
1.5
promille
1.2
1.3
0.34
48
465
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
10
78
1.28
0.24
1.1
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
198
2068
0.96
0.24
1.6
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
84
900
0.93
0.24
1.4
1.4
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
5
38
1.32
0.23
4.6
7.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
35
313
1.12
0.23
1.8
1.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
102
961
1.06
0.22
1.5
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
131
1244
1.05
0.22
1.8
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
145
1522
0.95
0.22
1.2
1.3
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.3
—
115.5
—
0
11
(3002079) Sodium [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.1
—
128.3
—
0
11
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
32
355
0.90
0.20
1.4
1.3
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
36
326
1.10
0.20
2.7
2.2
umol/l
54.7
54.5
0.01
30
272
(3011335) Digoxin [Mass/volume] in Serum or Plasma
6
51
1.18
0.19
2.2
2.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1264
12482
1.01
0.18
2.8
2.9
ug/l
0.8
0.7
0.43
821
7974
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
49
453
1.08
0.18
1.0
1.0
ng/l
282.0
323.3
0.86
41
320
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
49
454
1.08
0.18
1.0
1.0
ng/l
830.2
731.7
0.81
41
312
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
70
743
0.94
0.17
1.3
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
24
268
0.90
0.17
1.3
1.5
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
66
0.76
0.17
1.6
2.5
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
49
457
1.07
0.16
1.0
1.0
ng/l
40.0
43.9
0.35
39
317
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
40
431
0.93
0.15
1.2
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
9
81
1.11
0.15
1.1
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
17
150
1.13
0.14
1.3
1.4
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
8
98
0.82
0.13
1.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
209
2141
0.98
0.12
1.4
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
82
853
0.96
0.11
1.8
1.7
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
15
167
0.90
0.10
4.9
5.9
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
15
167
0.90
0.10
2.5
3.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
5
44
1.14
0.10
1.0
1.7
ng/l
155.8
193.3
—
5
39
(3001729) Color of Synovial fluid
5
61
0.82
0.08
1.4
1.5
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
5
62
0.81
0.08
1.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
7
67
1.04
0.08
1.0
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
17
157
1.08
0.07
1.3
1.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
9
87
1.03
0.07
4.1
9.8
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
22
207
1.06
0.06
1.3
1.4
—
—
—
0
0
(4133840)
18
191
0.94
0.04
1.1
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
10
109
0.92
0.04
3.0
6.7
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
92
932
0.99
0.02
1.3
1.2
mmol/l
7.2
7.3
0.13
74
693
(1001926) Buprenorphine [Presence] in Urine by Screen method
199
1980
1.01
0.01
1.9
2.3
—
—
—
0
0
(44806420)
16
166
0.96
0.00
2.3
2.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
11
114
0.96
0.00
1.4
1.9
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
60
596
1.01
0.00
1.4
1.4
pmol/l
70.5
119.2
0.46
23
187
(3009466) Valproate [Moles/volume] in Serum or Plasma
104
1038
1.00
0.00
4.4
5.1
umol/l
347.6
367.3
0.72
93
901
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
14
139
1.01
0.00
1.7
2.1
umol/l
22.1
17.0
1.04
14
139
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012932) Hazelnut IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
18.7
—
0
7
(3029612) Listeria sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
0
6
0.00
0.00
0.0
1.0
—
159.8
—
0
6
(3036005) Urine sediment comments by Light microscopy Narrative
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
0
7
0.00
0.00
0.0
2.0
—
5.1
—
0
7
(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline
0
8
0.00
0.00
0.0
1.0
—
200.8
—
0
8
(3006598) pH of Arterial cord blood
6
63
0.95
0.00
1.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint D3_IMMUNEMECHANISM and mortality.

Females

Parameter HR [95% CI] p-value
D3_IMMUNEMECHANISM 1.833 [1.67, 2.01] < 0.001
Birth year 1.001 [0.99, 1.01] 0.845

During the follow-up period (1.1.1998 — 31.12.2019), 2580 out of 16776 females with D3_IMMUNEMECHANISM died.

Males

Parameter HR [95% CI] p-value
D3_IMMUNEMECHANISM 1.846 [1.68, 2.02] < 0.001
Birth year 0.988 [0.98, 1.0] 0.008

During the follow-up period (1.1.1998 — 31.12.2019), 2825 out of 15385 males with D3_IMMUNEMECHANISM died.

Mortality risk

Mortality risk for people of age

years, who have D3_IMMUNEMECHANISM.

N-year risk Females Males
1 0.141% 0.314%
5 1.333% 2.152%
10 3.185% 5.232%
15 6.206% 10.295%
20 10.567% 17.253%

Relationships between endpoints

Index endpoint: D3_IMMUNEMECHANISM – Certain disorders involving the immune mechanism

GWS hits: 10

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data